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Reliable technologies for the detection of chemical and biological 
substances are of great scientific importance and economic interest because of 
their vital applications in clinical diagnosis, environmental monitoring, 
forensic analysis and antiterrorism. In this regard, conjugated polyelectrolytes 
(CPEs) with electron-delocalized fluorescent backbones and water-soluble 
ionic side chains have provided a unique platform for the construction of 
biosensors. However, fast, simple and label-free visual sensing strategies 
remain lacking in CPE-based assays. In this thesis, a series of new CPEs are 
designed and synthesized to constitute effective förster resonance energy 
transfer (FRET) probes for label-free visual detection of physiologically 
important biomolecules such as heparin, double-stranded DNA (dsDNA), and 
proteins. Two kinds of FRET probes are developed, which include the CPEs 
with intramolecular energy donor-acceptor architecture (single-component 
systems) and the CPE blends with energy donor-acceptor pair (bicomponent 
system). In general, these CPE-based probes vary the fluorescent colors upon 
interacting with the targets of interest due to enhanced FRET, consequently 
making visual sensing feasible. As nonspecific interactions between CPEs and 
biomolecules are inevitably in existence and likely to disturb fluorescent 
signals, two molecular engineering methods are created to increase the 
detection selectivity. Incorporation of fluorescent dyes with biorecognition 
capability as the energy acceptor to the CPEs significantly enhances the 
detection selectivity, allowing for visual detection of dsDNA even in mixed 
samples; whereas, attachment of biorecognition groups to both the donor and 
 vi 
 
acceptor of the CPE-based biocomponent probes is proven to be effective in 
highly selective visual detection of a specific protein. In addition to label-free 
visual detection in solution, efficient FRET in cell is observed for the CPE-
based probes, which enables to light up and visualize the cellular structure 
using the commercial dyes with low brightness. Such a primary application in 
cell not only illustrates the importance of three-dimensional nanoparticle 
architecture of CPE in achieving whole-cell permeability, but also offers the 
opportunities of CPE-based probes in cellular sensing and imaging 
applications. The label-free visual assays developed herein together with the 
underlying mechanisms unraveled thereof should also provide useful 
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1.1. Conjugated Polyelectrolyte Based Biosensors 
Reliable technologies to detect chemical and biological substances are of 
vast scientific and economic importance because of their wide applications in 
clinical diagnosis, environmental monitoring, forensic analysis and 
antiterrorism.1 In particular, the fast-growing research fields of genomics and 
proteomics have stimulated the extensive investigations in the development of 
novel biosensors for the efficient, convenient and specific detection of 
biomolecules of interest. Biosensor can be defined as a device that converts a 
selective biochemical interaction between the biologically-active substance 
(known as a biorecognition element) and the target specie into a measurable 
analytical signal (e.g. electrochemical, mass, and optical signals).2-5 In 
comparison with those based on electrochemical and mass signal outputs, 
optical biosensors nowadays play a relatively dominant role in the commercial 
market owing to their ease of detection, flexibility, sensitivity, and tenability.  
The progress of biosensors is highly dependent on the advances in 
materials chemistry and engineering, which can lead to the availability of new 
sensory materials for biorecognition as well as for signal transduction. In 
particular, polymeric functional materials that can be utilized as signal 
transducers or biorecognition elements, or even the combinatorial thereof 
provide the opportunities to construct biosensors allowing for the trace 
detection of analytes in a convenient, real-time and continuous manner.3-6 In 




expedient category of versatile polymeric building blocks for the construction 
of reliable optical biosensors.  
CPEs can be characterized as π-conjugated polymers (CPs) with water-
soluble ionic side chains.7-9 The charged side chains of CPEs orchestrate 
electrostatic interactions as a function of a given recognition event, while their 
electron-delocalized conjugated backbones behave as light-harvesting 
antennas to transduce and amplify optical outputs that are more sensitive as 
compared to small-molecule chromophores. Therefore, CPEs can be 
recognized as the excellent sensory materials combining biorecognition ability 
with signal transduction, consequently enabling one to facilely finetune their 
molecular structures for detection of various biological targets of interest, such 
as glucoses, nucleic acids, peptides, proteins and even bacterias.10-16  
Traditional CPE-based assays widely rely on fluorescence quenching as 
the signal readout.1,6,9 This general strategy is inspired by the observation that 
quenching of CPs upon binding to strong electron-withdrawing quenchers 
(such as explosives) via charge transfer is much more efficient than that of 
their small molecule counterparts.6 In contrast to direct quenching, some 
analytes may also indirectly induce fluorescence quenching through polymer 
aggregation caused by electrostatic/hydrophobic interactions, leading to self-
quenching of polymer fluorescence.3 Apart from super-quenching, light-
harvesting properties of CPEs also enable them to act as energy donors to 
amplify the signal output of fluorophores attached to biomolecular probes via 
fluorescence resonance energy transfer (FRET).7 The working mechanism 
capitalizes on the distance-dependent FRET between CPE and fluorophore-




fluorescence signals. In addition to fluorescent assays, colorimetric assays can 
be developed by taking advantage of the conformation-sensitive absorption 
properties of CPEs.5,7,10 However, only water-soluble polythiophenes (PTs) 
are effective in colorimetric assays, while other CPEs, such as water-soluble 
poly(p-phenylene) (PPs), poly(p-phenyleneethylene)s (PPEs) poly(p-
phenylenevinylene)s (PPVs) and polyfluorene (PFs) derivatives are generally 
applicable for fluorescent assays.  
Although CPEs have formed a unique basis for the construction of 
biosensors with various optical signal outputs, selectivity, sensitivity and 
simplicity of CPE-based assays still need to be optimized so as to facilitate 
their practical applications.7-10 In particular, fast, simple and instrument-free 
visual sensing strategies remain lacking. However, visual detection is essential 
for on-site diagnosis in disaster situations or in poorly equipped rural areas, as 
it eliminates the need for sophisticated analytical instrument. On the other 
hand, visual biosensors offer the opportunity for the patients to in-situ carry 
out pre-diagnosis at the very early stage of diseases. Furthermore, they allow 
for monitoring of the clinical outcome during the treatment at home by the 
patients themselves, providing the real-time information for personalizing the 
drug dosing level. Such a convenience in early-stage diagnosis and real-time 
therapeutic monitoring can greatly increase the chances for successful 
treatment. 
Few existing CPE-based assays are capable of visual detection. However, 
as the occurrence of FRET process is usually accompanied with the 
conversion in emission intensities between energy donor and acceptor, FRET-




of biomolecules. Furthermore, the dual-channel signal collection of FRET 
biosensors leads to the distinguished advantage such as reduced probability of 
false-positive signals and enhanced sensing reliability in comparison with 
fluorescence on/off and colorimetric protocols.7, 10 As a result, development of 
CPE-based FRET biosensors is of high demand and importance for visual 
detection.  
1.2. Research Objectives  
Despite the great potential of CPE-based FRET assays in visual detection, 
they have been rarely developed for this purpose. Moreover, current CPE-
based FRET biosensors generally require the participation of dye-attached 
probes to act as energy acceptors and biorecognition elements in the detection 
procedure. As chemical modification of biomolecules is always time-
consuming, expensive and likely to impair their original affinity and 
specificity toward target species, the sensing performance of these sensors is 
greatly constrained. In addition, the use of dye-attached probes (e.g. aptamers 
and antibodies) usually results in a relatively low fluorescent brightness as 
well as strong nonspecific electrostatic and hydrophobic interactions within 
the assay system, making them less applicable in visual sensing.  
From the viewpoint of application scope, current CPE-based FRET assays 
are only limited to the detection of biomolecules in solution or solid states, 
while no attempt has been devoted to perform the CPE-based sensing in cell. 
However, the signal amplification capability of CPE could lead to high 
fluorescence signals at low dye concentration with minimal laser power; this 




cellular or living systems. Thereby, utilization of CPEs for intracellular FRET 
is of biological significance.  
With these considerations, this Ph. D. project aims to develop CPE-based 
label-free biosensors with direct visual capability using FRET protocol.  
(i) Two kinds of FRET systems purely built on CPEs are developed for 
label-free sensing, which include the CPEs with energy transfer architecture 
(single-component systems) and the CPE-based blend with energy transfer 
partner (bicomponent systems). For the former, the energy acceptor can be 
located within the polymer backbone or attached to the side chain; for the later, 
the energy acceptor can be CPEs, water-soluble neutral conjugated oligomer 
and even commercial dyes. Although polymers with energy donor-acceptor 
structures have been widely developed, few have been used for visual 
biosensing. Moreover, it is the first time that CPE blends are used to form 
FRET systems for sensing applications.  
(ii) Typical biomolecules of physiological and clinical importance 
including heparin, double-stranded DNA (dsDNA), and proteins are chosen as 
the target species in order to demonstrate the generality of the CPE-based 
FRET probes in visual sensing. Firstly, we take advantage of aggregation-
enhanced FRET properties of the CPE with energy transfer backbone in 
conjunction with electrostatic-attraction-induced polymer aggregation to 
realize visual detection of heparin. Secondly, we attach an intercalating dye to 
the CPE as the side chain to act as both biorecognition element and energy 
acceptor for highly-selective visual discrimination of dsDNA from single-




donating CPEs with energy-accepting CPE or neutral water-soluble 
conjugated oligomer to form bicomponent FRET systems for visual detection 
of ferritin and Concanavalin A (ConA), respectively.  
(iii) FRET is performed in cell and used to visualize the cellular structure 
so as to extend the application of CPE-based FRET strategy. This is the most 
challenging task in this project, because efficient cell-permeability is required 
as the precondition for the CPEs to be used for intracellular FRET. Since 
traditional CPEs are macromolecules showing dynamic and complicated 
structure and organization in aqueous solution, they are not as favorable as 
spherical nanoparticles for cellular uptake. Considering this limitation of CPEs, 
we utilize polyhedral oligomeric silsesquioxanes (POSS) as the framework to 
synthesize a single-molecular CPE-based nanoparticle. With its rigid and 
ultrasmall size, whole-cell permeability is observed, enabling to amplify dye 
fluorescence throughout the cell via FRET.  
Through this Ph.D. project, it is anticipated that not only a new generation 
of CPE-based FRET probes would be exploited, but also new opportunities 
and fundamental guidelines would be illuminated to pave the way for further 
development of CEP-based in-vitro and in-vivo biosensors.  
1.3. Thesis Outline 
This doctoral thesis consists of eight chapters. Chapter 1 describes the 
general research background, the motivation and objectives of this project as 
well as the thesis outline. Chapter 2 expatiates on the literature review for the 
existing four types of CPE-based biosensors (e.g. fluorescence quenching, 




biosensors are discussed in more details in terms of detecting species and also 
influencing factors for FRET, as this work is mainly relied on this protocol.  
Chapters 3 and 4 are regarding single-component FRET systems. Chapter 
3 represents the design and synthesis of a cationic CPE with an energy transfer 
backbone for label-free visual detection and quantification of heparin. The 
effect of electrostatic interactions in energy transfer properties of the CPE is 
investigated and revealed, which provides guidelines for polymer design in the 
following chapters. In Chapter 4, a CPE tethered with an intercalating dye as 
the side chains is developed for label-free visual detection of dsDNA, which 
has good selectivity even in serum-containing medium.  
Chapters 5-7 are regarding bicomponent FRET systems. Chapter 5 shows 
the label-free visual detection of proteins based on the nonspecific-interaction-
perturbed FRET within a bicomponent CPE blend. In Chapter 6, the 
selectivity for visual detection of proteins is further optimized through 
molecular engineering of CPE blend. A water-soluble neutral conjugated 
oligomer instead of charged CPEs is applied as the energy acceptor, and both 
the energy-donating CPE and energy-accepting oligomer are attached with 
biorecognition groups as the side chains. In Chapter 7, a CPE-based 
unimolecular nanoparticle is designed and synthesized to have whole-cell 
permeability, which allows for signal amplification in cell via FRET and thus 
visualization of cellular structure.  








2.1. Conjugated Polyelectrolytes 
CPs are polyunsaturated macromolecules in which all backbone atoms are 
sp1- or sp2-hybridized.17 CPs in their neutral states are organic semiconductors 
that exhibit efficient absorption and emission.18 Their bandgaps can be 
desirably fine-tuned by backbone structures, allowing emission ranging from 
ultraviolet to near infrared.19 Representative CPs include polyacetylene (PA), 
polydiacetylene (PDA), polyaniline (PAN), polypyrrol (PPy), polythiophene 
(PT), poly(p-phenylene) (PPP), poly(p-phenylenevinylene) (PPV), poly(p-
phenyleneethylene) (PPE), and polyfluorene (PF) as shown in Scheme 2.1. 
 
Scheme 2.1. Chemical structures of representative CPs (R: alkyl or alkoxy 
groups) 
During the past decades, CPs have been extensively investigated for their 
applications in optoelectronic devices, such as polymer light-emitting diodes 
(PLEDs),20 polymer light-emitting electrochemical cells (PLECs),21 
photovoltaic cells,22 organic field effect transistors (OFETs),23 and organic 




trace detection of analytes in a variety of environments,1 which benefit from 
their easily-perturbed properties, including charge transport,2 conductivity,3 
emission,4 and absorption.5 In particular, their delocalized electronic structure 
facilitates electronic coupling between optoelectronic segments and efficient 
intrachain and interchain energy/electron transfer.6 As compared to small 
molecule fluorophores, CPs have larger absorption cross-sections and unique 
collective optical responses, making them superior in the transduction of 
optical signals.7  
Water solubility, a prerequisite for fluorescent materials to interrogate 
biomolecules of interest in physiological environment, necessitates the 
development of water-soluble CPs. CPEs are a kind of CPs with water-soluble 
side chains.8 These polymers combine the optoelectronic properties of CPs 
with the charge-mediated behaviors of polyelectrolytes,9 providing a unique 
platform for the construction of chemical and biological sensors.10-16 
According to charge sign, water-soluble CPEs can be simply divided into three 
categories, cationic CPs (CCPs), anionic CPs (ACPs) and neutral CPs (NCPs). 
The chemical structures of some typical CPEs are summarized in Scheme 2.2. 
Cationic groups of CCPs are usually quaternary ammonium (CCPs 1-3), while 
anionic groups of ACPs are sulfonate (4-7), phosphonate (8), or carboxylate 
(9). The NCPs usually has polyethylene glycol or sugar side chains (10 and 11) 
as the hydrophilic groups to endow water solubility.  
The water-solubility of CPEs is not only dependent on the ionic side 
groups but also affected by the hydrophobic aromatic backbones.25 More 
importantly, the presence of charged side groups in CPEs results in 




emerge as indispensable driving forces to bring them into close proximity to 
change the optical properties of CPEs.26-28  
 




Due to the aromatic backbones of CPEs, the hydrophobic interactions 
usually coexist with electrostatic attractions to participate in the sensing 
processes.29 As such, the electrostatic and hydrophobic interactions functions 
in the course of a given recognition event, while the electron-delocalized 
conjugated backbones of CPEs behave as light-harvesting antennas to amplify 
the optical output. CPEs hence emerge as a new generation of promising 
functional materials appropriate for utility as signal transducers and 
recognition elements in biosensors.  
2.2. Fluorescence Quenching Sensors 
Traditional CPE sensors rely on the intensity decrease in the polymer 
fluorescence upon binding of an analyte, known as fluorescence quenching.30 
The first example of fluorescence quenching sensing was demonstrated using 
organosoluble CPs by Swager’s group in 1995.31 The significant finding of 
this report is that fluorescence quenching of CPs upon binding to strong 
electron-withdrawing quenchers (such as explosives) is much more effective 
than that of their small molecule counterparts. This phenomenon is termed as 
“molecular wire effect” or “superquenching” as illustrated in Scheme 2.3, 
which results from the CP’s delocalized electronic structure that facilitates 
efficient charge transfer over a long distance to the quencher. To quantify a 
fluorescence quenching process, the Stern-Volmer equation can be applied:32 
0 SVI / I 1 [Q]K                                          (Eq. 1.1) 
Where, I0 and I are defined as the emission intensities in the absence and 




quencher. KSV is the Stern-Volmer constant, which provides a quantitative 
measure of quenching efficiency. 
 
Scheme 2.3. Illustration of “molecular wire effect” using fluorescence 
quenching of CPs as an example. 
The most widely exploited processes for directly quenching the intrinsic 
fluorescence of a CPE are charge transfer between the polymer and a 
quenching analyte species.33 For instance, detection of proteins by 
fluorescence quenching signatures of CPEs has been demonstrated by Heeger 
et al. in 2002.34 Cytochrome c (CytC), an iron-containing protein, can be 
distinguished from myoglobin and lysozyme by using an anionic butoxy-
substituted PPV (4, Scheme 2.2). Detection of CytC at a concentration of 10-11 
M was possible. The quenching response of 4 was ascribed to electron transfer 
from the photoexcited polymer to CytC, and the large Stern-Volmer constant 
(KSV) was proposed to be partially due to the formation of an electrostatic 
complex between the oppositely charge CPE and protein that favors the 
electron transfer between them.  
Nonquenching analytes may also indirectly cause fluorescence quenching 
through inducing aggregation of the fluorescent species via electrostatic or 




Fluorescence self-quenching is any interaction between an excited molecule 
and a ground-state molecule of the same type that induces non-radiative 
deactivation of the excited state.36 CPEs substituted with sugar residues have 
found use in direct sensing applications related to the lectins and cells.37 Bunz 
et al. synthesized mannose-functionalized PPE (10, Scheme 2.2), which was 
applied for the detection of Concanavalin A (Con A). 10 showed efficient 
fluorescence quenching in the presence of Con A with KSV = 5.6 × 106, while 
its fluorescence was insignificantly affected by bovine serum albumin (BSA) 
and jacalin, a galactose-binding protein. The selective quenching was ascribed 
to the aggregation-induced self-quenching of 10 in the presence of Con A.  
 
Scheme 2.4. Schematic illustration of (a) the displacement of a quenched 
fluorescent PPE by protein analyte (in blue) from gold NPs to recover the 
fluorescence, and (b) unique fluorescence pattern generation through 
differential release of PPEs.38 Copyright 2007 Nature Publishing Group. 




Bunz’s and Rotello's groups also cooperatively developed a protein array 
based on nonspecific interactions induced fluorescence quenching of CPEs.38 
The sensor array contained six non-covalent gold nanoparticle (NP)-CPE 
aggregates. The detection scheme is illustrated in Scheme 2.4. Initially, the 
fluorescence of 9 was quenched by the gold NPs. These NPs were engineered 
with different hydrophobic functional groups to tune the interactions between 
the NPs and polymers or proteins. Upon addition of proteins, the interaction 
between gold NPs and CPs was disrupted and the displacement of the 
polymers by proteins on the NP surface led to distinct fluorescence response 
patterns. These patterns were highly repeatable for each individual protein, 
providing a robust platform for multi-protein detection with nanomolar 
sensitivity. The same groups further reported a sensor array containing six 
functionalized PPE derivatives, each of which possessed distinct charge 
characteristics and molecular scales to provide different binding diversities 
upon interaction with protein analytes.39 The distinct fluorescence response 
pattern allowed the identification of 17 different proteins with a high accuracy 
of 97%. 
Whitten’s group in 2004 reported the indirect detection of proteins using 
CPE-based assay, which involves specific metal/protein interactions.40 
Kinases control the phosphorylation/dephosphorylation of serine, threonine, 
and tyrosine residues, affecting and regulating a variety of cellular processes.41 
Quaternary ammonium-functionalized latex microspheres are coated with an 
anionic alternating PPE (6, Scheme 2.2). The polymer-coated microspheres 
are then exposed to GaCl3, giving rise to Ga3+-functionalized microspheres as 




Ga3+ coat endues the microspheres with an affinity for phosphorylated 
peptides. Monitoring fluorescence quenching of 6 within Ga3+-functionalized 
microspheres allows for the detection of kinase activity. The assay takes 
advantage of a peptide substrate labeled with a rhodamine dye at its N-
terminus. In the absence of kinase activity (peptide phosphorylation), the dye-
attached peptide cannot bind to the fluorescent microspheres due to the 
electrostatic repulsion. Upon kinase-activated phosphorylation, the peptide 
associated with the Ga3+-coated microspheres via Ga3+-phosphate binding. 
CPE-coated microsphere fluorescence was quenched upon close association 
with the dye-attached phosphorylated peptide.  
2.3. Fluorescence Turn-on Sensors 
Investigation on small fluorophore based sensors have pointed out that 
fluorescence turn-on sensors have crucial advantages of reduced probability of 
false positive signals and increased sensitivity as compared to fluorescence 
turn-off sensors.42-44 Efforts also have been devoted to the development of 
CPE-based assays involving fluorescence enhancement response upon binding 
of analyte.  
Photoinduced electron transfer (PET) mechanism has proven to be useful 
in designing fluorescence turn-on CPE chemosensors. Recently, a series of 
PET based poly[p-(phenyleneethynylene)-alt-(thienyleneethynylene)] (PPET) 
have been reported by Jones’s group to show a fluorescence increase in the 
presence of certain metal ions.45 This is ascribed to the disrupted PET from the 
electron-deficient side chains to the conjugated backbone upon metal chelation. 




the preloading of cupric ions onto the electron receptors to quench the polymer 
emission for improved sensitivity.46 Besides, they are not water-soluble, and 
thus less appropriate for detection in biological media.  
Indicator displacement mechanism can also be utilized to fabricate the 
fluorescence turn-on CPE biosensors. Schanze et al. reported a fluorescence 
turn-on sensor for pyrophosphate detection based on the hybrid system of a 
carboxyl-substitute PPE (9) and Cu2+.47 The detection scheme is shown in 
Scheme 2.5. This assay made use of the high affinity between pyrophosphate 
and Cu2+, which reduced the contact between the polymer and Cu2+ and 
subsequently led to the recovery of the polymer fluorescence prequenched by 
Cu2+. These sensors are inconvenient due to the requirement of prequenching 
procedure, which limits their applications in analyte detection.  
 
Scheme 2.5. Schematic illustration of indicator displacement mechanism for 
pyrophosphate detection.47  
Similarly, fluorescence de-quenching approach is used to monitor protein 
activity, which takes advantage of a quencher-labeled biomolecular complex. 
This complex can be hydrolyzed by an active enzyme to release the quencher 




Schanze's and Whitten's groups reported several significant studies about 
CPE-based fluorescent assays for enzyme activity study using anionic PPEs in 
solution or anionic PPE-coated fluorescent microspheres as the probes.48 A 
typical assay scheme is shown in Scheme 2.6. The fluorescence turn-on 
approach contains an anionic PPE (7) and a cationic peptide (the enzyme 
substrate) labeled with p-nitroanilide as the quencher. Electrostatic attraction 
between the anionic 7 and the cationic peptide leads to fluorescence quenching 
of the polymer by p-nitroanilide. In the presence of a proteolytic enzyme, 
peptidase, the quencher-labeled peptide is hydrolyzed and the quencher is 
released. As the free p-nitroanilide is neutral, it is unable to associate with the 
polymer and the solution fluorescence is recovered. 
 
Scheme 2.6. Schematic illustration of CPE-based turn-on and turn-off assays 
for protease activity study.48 
2.4. Colorimetric Sensors 
Colorimetric sensors utilize the changes in a material’s absorption 
properties as the signal output. Although the CPs absorption characteristics are 
largely determined by the local electronic structure, the sensitivity of the band 




of sensor. CPE-based colorimetric biosensors have been well established on 
water-soluble PT,49,50 which take advantage of the sensitive conformation-
dependent optical properties of PT.51,52 A label-free DNA hybridization 
detection assay based on PT (3) is presented in Scheme 2.7. Electrostatic 
attractions play an important role in bringing the oppositely-charged polymer 
and DNA into close proximity to form interployelectrolyte complexes, within 
which the polymer conformation is determined by the strand number of 
DNA.53 DNA hybridization event hence can be monitored by the colorimetric 
transition of the polymer from deep violet (absorption maximum at ~550 nm) 
to bright yellow (absorption maximum at ~425 nm), as a result of the polymer 
conformation variation from coplanar rigid rod to twisted random coil upon 
hybridization. 
 
Scheme 2.7. Schematic illustration of the formation 3/ssDNA duplex and 
3/hybridized dsDNA triplex.53 
Protein detection was also realized based on the colorimetric behaviors of 
PT. A combined system of a cationic PT derivative and an anionic single-
stranded DNA as specific aptamer (5'-GGTTGGTGTGGTTGG-3') were 
applied for the detection of human α-thrombin (Scheme 2.8).54 PT, as a 




target protein into a clear colorimetric signal. The 1:1:1 complex between the 
PT, the aptamer, and thrombin has an orange color. The thrombin promotes 
the formation of the quadruplex form of thrombin/aptamer. As such, the PT 
wraps this quadruplex structure, which would partially hinder the aggregation 
and planarization and in turn leads to a red-violet color of the PT.  
 
Scheme 2.8. Schematic illustration of the specific detection of human α-
thrombin using a ssDNA thrombin aptamer and a cationic PT.54  
Small molecules with less negative charges in contrast to DNA and 
proteins can also be discriminated by using cationic PT as the colorimetric 
probe. Shinkai and co-workers reported a cationic PT-based selective sensor 
for adenosine triphosphate (ATP).55 As shown in Scheme 2.9, exposure of 3 to 
increasing concentrations of ATP (up to 5 × 10-4 M) in water leads to a 
pronounced 138 nm red shift in the absorbance spectra, changing the solution 
color from yellow to pink-red. The mechanism is associated with the 




causes conformational changes from random-coil to linear chains. Increased 
planarity of the polymer induced stacked aggregation. As the positive response 
to uridine triphosphate (UTP) and the weaker response to inorganic 
phosphates (HPO42−), the presence of hydrophobic nucleoside structure should 
also play an important role in inducing aggregation and in turn the 
colorimetric responses of 3. The responses of 3 to adenosine diphosphate 
(ADP) and adenosine monophosphate (AMP) are significantly weaker as 
compared to ATP (Scheme 2.9). This work highlights that cationic PT can be 
utilized as colorimetric probe to discriminate small molecules with different 
net negative charges and hydrophobicity. Similarly, colorimetric 
discrimination of other targets such as peptide,56 amines,57folic acid,58 and 
heparin 59 has also been realized using water-soluble PT derivatives. 
 
Scheme 2.9. Colorimetric responses of 3 (0.1 mM, water) toward various 
anions.55 Copyright 2006 Wiley-VCH Verlag GmbH & Co. KGaA. 
Reproduced with permission from Ref 55.  
2.5. FRET Sensors 
CPE-based sensors involving FRET are of growing scientific interest and 
importance owing to their vital advantages over fluorescence quenching and 
colorimetric sensors, such as detection versatility and multichannel signal 
collection.60 FRET is a well-known photophysical process whereby individual 




transferring excitons from a donor to an acceptor.61 Since FRET is sensitive to 
intramolecular and intermolecular distance in the range of 1 to 10 nm, it has 
been widely adopted as a reliable pathway of signal transduction in 
biochemical research.62  
The application of CPEs in FRET biosensors were motivated by two main 
concerns. On the one hand, the strong distance-dependent FRET is especially 
effective in CPE-based sensing because changes in the distance between CPE 
and chromophore or chromophore-labeled probe can be facilely correlated 
with the recognition events and subsequently converted into measurable 
fluorescence signals from both acceptor and donor emission intensities. On the 
other hand, CPEs having efficient light-harvesting properties and high 
extinction coefficients are natural high-performance energy donors, allowing 
for amplified fluorescence of energy acceptors to yield high sensitivity with 
low signal-to-noise ratio.  
In 2002, Gaylord, Bazan and Heeger reported for the first time a CPE-
based FRET assay to detect specific DNA sequences using a dye-attached 
PNA probe.63 Cationic poly[9,9-bis(6'-N,N,N-trimethylammonium)-hexyl]-
fluorene phenylene) diiodide (1I, Scheme 2.1) was chosen as the donor 
molecule in view of its high-energy emission and sufficient PL quantum yield 
in aqueous media. This important report paves the way for the succeeding 
work concerning chemical and biological detection using CPEs as energy 
donors. As follows, CPE-based FRET sensors will be summarized and 
cataloged according to the detection species, and then the factors that 




2.5.1. DNA Detection 
The working mechanism of CCP-based DNA assay using FRET protocol 
is illustrated in Scheme 2.10.63 Emission of light characteristic of the signaling 
C*, upon excitation of the CCP, indicates the presence of the target 
oligonucleotide. Transduction by electrostatic interactions induced energy 
transfer is an essential component of the general strategy. The assay contains 
two ingredients: (a) a light harvesting CCP and (b) a probe oligonucleotide 
consisting of a peptide nucleic acid (PNA) labeled with C*.  
 
Scheme 2.10. Schematic illustration of the working mechanism of CCP/PNA-
C*/DNA sensor.63 
The assay illustration is shown in Scheme 2.10. One begins with a 
solution that contains a CCP and a PNA-C*. The optical properties of the CCP 
and C* are optimized for efficient FRET from CCP (donor) to C* (acceptor). 
Because PNA is neutral, there are no electrostatic interaction between PNA-
C* and the CCP. In the presence of ssDNA, two situations may occur. 
Situation A: hybridization of the neutral PNA-C* to the complementary 
ssDNA causes the formation of PNA-C*/ssDNA duplex and in turn the 




charges. As such, electrostatic attraction between the PNA-C*/ssDNA duplex 
and CCP occurs to bring the dye sufficiently close to the CCP to favor FRET, 
leading to intense emission from C*. Situation B: in the presence of a non-
complementary ssDNA, hybridization does not occur and the CCP binds 
preferentially to ssDNA. One determines whether the target strand is 
complementary to the PNA probe by monitoring the C* emission upon CCP 
excitation. 
Scheme 2.10 was first tested using a water-soluble CCP 1I and a PNA 
probe (5'-Fl-CAG TCC AGT GAT ACG-3', PNA1-Fl).63 The absorption and 
emission spectra of 1I and PNA1-Fl are shown in Figure 2.1A. Good overlap 
between the emission of 1I and the absorption of Fl ensures FRET. Energy 
transfer was optimized by varying the ratio of 1I to PNA-C*. Figure 2.1B 
shows the PL spectra of the solution of PNA1-Fl (2.5 × 10 -8 M, based on the 
PNA strand) and 1I (2.5 × 10 -8 M, based on polymer chain) in the presence of 
ssDNA upon excitation of 1I at 380 nm. Intense Fl emission is induced in the 
presence of the complementary ssDNA1 (sequence: 5'-CGT ATC ACT GGA 
CTG-3'), whereas only a minor signal is observed for the noncomplementary 
ssDNA2 (sequence: 5'-ACT GAC GAT AGA CTG-3'). The amplified signal 
upon excitation of CCP at 380 nm is ~25 times higher than that upon direct 
excitation of Fl at its absorption maximum (480 nm). This leads to a detection 
limit of 10 pM with a standard fluorometer. The F1 emission in the presence 
of ssDNA2 can be further decreased by using a solution containing 10% 
ethanol. Under the identical experimental used for Figure 2.1B, the presence 




CCP, consequently reducing Fl emission by a factor of 3 in the presence of 
ssDNA2, making the signal almost undetectable with a standard fluorometer.  
 
Figure 2.1. (A) Absorption [(a) green and (c) orange] and emission [(b) blue 
and (d) red] spectra of CCP 1I and single-stranded PNA1-Fl, respectively. 
Fluorescence was measured by exciting at 380 and 480 nm, for 1I and PNA1-
Fl, respectively. (B) PL spectra of PNA-C* in the presence of complementary 
[(a) red] and noncomplementary [(b) black] DNA by excitation of CCP 1. 
Conditions are in water at pH = 5.5. The spectra are normalized with respect to 
the emission of CCP 1I.63 Copyright 2002 National Academy of Sciences U S 
A. Reproduced with permission from Ref 63. 
Scheme 2.10 was subsequently modified to use chromophore-labeled 
ssDNA (ssDNA-C*) as the signaling probe instead of PNA-C* considering 
that ssDNA-C* is more common and cost-effective than PNA-C*.64 In this 
case, ssDNA3-F1 (5'-F1-GTA AAT GGT GTT AGG GTT GC-3') was used as 
the dye-attached nucleic acid probe, and energy transfer was examined for the 
complementary ssDNA4 (5'-GCA ACC CTA ACA CCA TTT AC-3') and the 
noncomplementary ssDNA5 (5'-GAC TCA ATG GCG TTA GAC TG-3'). A 
direct comparison of Fl emission (upon excitation at 380 nm) with [ssDNA3-
F1] = 2.1 × 10-8 M and [1I] = 5.1 × 10-7 M. Electrostatic attraction between 
ssDNA-Fl and CCP (1I) does occur, giving rise to background dye emission in 




intensity in the presence of ssDNA4 is 3-fold higher than that in the presence 
of ssDNA5. The difference in FRET is attributed to a closer proximity between 
Fl and 1I in the presence of ssDNA4 as compared to that in the presence of 
ssDNA5. This study indicates that utilization of ssDNA-C* instead of PNA-C* 
as the probe is less effective for DNA detection.  
This strategy was also examined by Leclerc’s group using a cationic PT in 
conjunction with ssDNA labeled with Alexa Fluor 546, where a detection limit 
of 3 zM was achieved.65 In addition, Wang et al. also used a similar scheme 
for SNP detection and allele frequency determination in association with probe 
extension reaction, where a DNA fragment as a part of p53 exon8 containing a 
polymorphic site (Arg282Trp) was effectively discriminated according to the 
difference in FRET.66  
2.5.2. Protein Detection 
Since many diseases do not have a specific genetic signature but rather a 
variation in protein expression, biosensors for protein detection are of 
particular significance in medical diagnostics and pathogen recognition.67 
However, proteins are much more complex and sensitive than oligonucleotides, 
which merit additional severe considerations in the course of assay design.68 
Immunoassays are conventional methods based on specific antibody-antigen 
recognition for protein detection. Enzyme immunosorbent assay (ELISA) is 
the most widely used immunoassay in clinics, which requires antibodies to be 
immobilized on the substrate to capture antigens and the secondary 
antibodies.69 The enzymes attached to the secondary antibodies serve as the 




demands tedious protein modification, surface immobilization, blocking and 
washing and is limited by the availability of commercial antibodies. Thus, 
there is an ever-growing and urgent demand for developing new protein 
detection strategies that are simple and economical, with high selectivity and 
sensitivity.  
FRET-based protein biosensors have been developed using CPEs as the 
light-harvesting donors in conjugation of “lock-key” recognition. Streptavidin 
is a tetrameric protein that binds up to four molecules of biotin with the 
dissociation constant estimated to be 4 × 10-14 M. In 2004, Zheng and Swager 
reported FRET experiments between a biotin-substituted PPE and three 
different dye-attached streptavidins.70 Among these dye-labeled streptavidins, 
TR-labeled streptavidin showed the highest FRET-induced dye fluorescence 
upon excitation of the biotin-substituted PPE, which was followed by 
rhodamine B-labeled streptavidin and then Fl-labeled donor streptavidin. Of 
significance is that a structurally similar PPE without biotin groups gave no 
observable FRET-induced dye emission, indicating the importance of specific 
antibody-antigen interaction in controlling FRET.  
In 2006, Wang et al. reported a specific streptavidin assay using 1Br as 
the light-harvesting donor and F1-labeled biotin (Fl-B) as the acceptor probe.71 
The working mechanism of this assay is illustrated in Scheme 2.11. Addition 
of analyte proteins into the solution of Fl-B leads to two situations. Situation A 
refers to the target protein, streptavidin. The biotin moiety of Fl-B strongly 
associates with streptavidin and Fl is deeply buried in the adjacent vacant 
binding sites. Thus, after addition of 1Br into the mixture solution, although 




B/streptavidin complexes, the distance between 1Br and Fl-B does not meet 
the requirement for FRET. As a result, the Fl fluorescence is weak. Situation B 
corresponds to a nonspecific protein, such as BSA. Under these conditions, Fl-
B remains separated from the protein. Therefore, electrostatic attraction 
between oppositely-charged 1Br and F1-B can bring them into close 
proximity, leading to efficient FRET from 1Br to F1 and thus strong F1 
fluorescence. The discrepancy in Fl emission intensity thus allows one to 
distinguish streptavidin from other proteins. 
 
Scheme 2.11. Schematic illustration of streptavidin assay operation.71 
Protein biochip for thrombin detection was also reported by Leclerc’s 
group using the complex of a cationic PT (12, Scheme 2.12) and dye-attached 
ssDNA aptamer as the FRET-based probe as illustrated in Scheme 2.12.72 The 
complex probe was prepared by stoichiometrically mixing CCP 12 with 3'-
Cy3-labeled ssDNA aptamer. Two ssDNA sequences were used, one was the 
specific thrombin aptamer, ssDNA9-Cy3 (5′-NH2-C6-




ssDNA10-Cy3 (5′-NH2-C6-GGTGGTGGTTGTGGT-Cy3-3′). The presence of 
amine group at the 5'-end of the ssDNA aptamer allows the complex of 
12/ssDNA to covalently binding onto treated glass slides to form the solid 
state array. 
 
Scheme 2.12. Illustration of the specific detection of target Proteins by using 
the complex of a cationic PT(12)/dye-attached ssDNA aptamer on glass 
slides.72 Copyright 2006 American Chemical Society. Reproduced with 
permission from Ref 72. 
In presence of thrombin, a significant fluorescence intensity increase is 
observed for the spots with 12/ssDNA9-Cy3 complexes (binding sequence). In 
the presence of two nonspecific proteins, BSA and immunoglobulin E (IgE), 




specificity of the detection with respect to the target. On the other hand, the 
spots with 20/ssDNA10-Cy3 complexes (nonbinding sequence) do not exhibit 
fluorescence enhancement for human thrombin, confirming the specificity of 
the detection in terms of the complex probe. Correlation of the fluorescence 
intensities as a function of proteins concentration using the spots of 
12/ssDNA9-Cy3 reveals a limit of detection of ~1.5 × 107 molecules for 
human thrombin (i.e., 6.2 × 10-11 M in 0.4 μL) together with a very good 
specificity. This work highlights that biochips can be established by taking 
advantage of CPEs in association with dye-attached aptamers, which opens 
new feasibilities for simple and rapid multiplex analysis in proteomics.  
2.5.3. Small Molecule Detection 
In addition to biological macromolecules (e.g. DNA and proteins), small 
molecules such as ions and toxic molecules can also be detected based on 
CPEs using FRET protocol. For instance, a CPE-based method to detect 
hydrogen peroxide (H2O2) has been developed, which was also able to 
indirectly probe glucose in conjunction with an enzymatic oxidase.73 The 
multifunction of such assay benefits from the fact that H2O2 is generated by 
almost all oxidases, and the concentration of H2O2 produced is closely related 
to the activity of oxidases, or the enzyme substrates (such as glucose herein). 
CCP 1Br and a boronatefunctionalized fluoresceine derivative (Fl-B) were 
chosen as the fluorescence reporting donor and acceptor, respectively. The 
assay scheme is illustrated in Scheme 2.13.  
In the absence of H2O2, the neutral F1-B is far from 1Br. Upon addition of 




Because F1 exists as a monoanion or dianion in the pH range 5.4-9.1, 
electrostatic attraction between 1Br and F1 emerges in PBS (pH = 7.4) to 
induce efficient FRET, leading to polymer quenching and enhanced Fl 
emission. Based on this method, hydrogen peroxide is detected down to 15 nM. 
In addition, such H2O2-mediated FRET between CCP 1Br and Fl-B can be 
further refitted for the detection of β-D-(+)-glucose by taking advantage of the 
oxidase-catalyzed reaction which generates hydrogen peroxide as a byproduct 
(Scheme 2.13).  
 
Scheme 2.13. Schematic illustration of the glucose sensor operation based on 
H2O2-mediated FRET between CCP 1Br and a boronatefunctionalized 
fluoresceine derivative (F1-B).73 
Addition of glucose to the mixture of 1Br, Fl-B and glucose oxidase 
results in production of H2O2 and in turn liberation of Fl, which quenches 
polymer fluorescence and increases dye emission through FRET. The limit of 
detection for glucose is 5 µM. This strategy has been further developed by 
attaching F1-B to 1Br as the side chain.74 In comparison with the mixed 




the effect of electrostatic attraction on intramolecular FRET, and the detection 
can be conducted in both buffer solution and serum.  
 
Scheme 2.14. Schematic illustration of K+ Sensor based on FRET between 
CCP and a G-rich dye-attached ssDNA.75 
On the other hand, a K+ sensor was constructed based on the difference in 
FRET between the dye-attached ssDNA with random coil conformation and 
that with G-quadruplex in the presence of K+.75 The working mechanism is 
illustrated in Scheme 2.14. 1Br was used as the donor, while ssDNA14-F1 (5'-
F1-GGT TGG TGT GGT TGG G-3') was used as the K+ sensitive recognition 
element. In the absence of K, ssDNA14-Fl complex is weakly associated with 
1Br and thus FRET from 1Br to Fl is relatively inefficient in this loose 
complex due to a large average donor-acceptor distance. On the contrary, 
addition of KCl promotes the conformational transformation of ssDNA14-Fl 
from a random coil structure to a K+-bound G-quadruplex. As such, the space 
charge density around the DNA macromolecules increases, leading to 




1Br to Fl in the presence of K+ becomes more efficient as compared to that in 
the absence of K+, resulting in increased FRET-induced F1 emission at 527 
nm. 
The relative emission intensity of Fl in the presence of 50 mM K+ is 16-
fold higher than that in the absence of K+ upon excitation of CCP at 380 nm. 
Furthermore, the emission intensity of Fl in the presence of other ions, such as 
Na+, NH4+, Li+, Mg2+, and Ca2+ is substantially lower than that in the presence 
of K+. These data indicate that this K+ sensor has good selectivity. However, it 
is noteworthy that in order to maintain a weak F1 emission at the initial state, 
the donor concentration ([1Br]) is well below the optimized concentration for 
the traditional DNA hybridization sensors where the positive/negative charge 
ratio is close to 1.  
2.5.4. Influencing Factors for FRET 
Considering that FRET is a crucial process that generates the signal and 
determines the signal intensity, factors influencing FRET between CPEs and 
organic fluorophores are summarized as follows. Equation 1 describes the 
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where, rDA is the donor-acceptor distance, τD is the lifetime of donor in the 




quantum yield of the donor in the absence of acceptor, N is Avogadro’s 
number, n is the refractive index of the medium, and k is the orientation factor. 
The overlap integral, J(λ), expresses the degree of spectral overlap between 
the donor emission, FD(λ), and the absorption of acceptor, єA(λ).  
The Förster equation is valid for ideal FRET processes when the donor 
and acceptor have well matched energy levels. Otherwise, a competing 
process to FRET, known as PET, is likely to occur. Although PET is a favorite 
mechanism for fluorescence quenching assays, it constitutes an undesirable 
energy-wasting channel in FRET assays that significantly reduces the 
fluorescence intensity and in turn the overall sensitivity.  
 
Scheme 2.15. Effect of relative orbital energy levels preferred for FRET and 
PET.  
Scheme 2.15 represents two possible situations upon excitation of the 
polymer donor. Situation A refers to the ideal situation for FRET, where the 
highest occupied molecular orbital (HOMO) and lowest unoccupied molecular 
orbital (LUMO) energy levels of the acceptor are well contained within the 
orbital energy levels of the donor. Upon excitation of the donor, FRET to the 
acceptor occurs to induce an emissive process. Moreover, direct excitation of 




character is particularly useful for monitoring whether PET process exists in 
the system and how strong could be. On the contrary, situation B favours PET, 
where both the electron affinity and the ionization potential are higher in one 
of the optical partners. As shown in Scheme 2.15, excitation of the donor 
would lead to PET to the acceptor, while excitation of the acceptor would 
result in a similar charge-separated state via hole transfer to the donor. 
Although Scheme 2.15 is widely used for choosing suitable optical 
partners for a specific application, it becomes less accurate for intermediate 
cases owing to the neglect of the contributions from the exciton binding 
energy, the intermolecular charge transfer state energy, and the stabilization of 
the charged species by the medium.76 The mechanism for the competition 
between FRET and PET is complex and less understood for the CCP/C* pairs, 
but it is still probable to minimize PET process by molecular design of CCP 
and the careful choice of donor/acceptor pairs.  
With these progresses in CCP-based assays, it is gradually recognized that 
interactions within the CCP/probe-C* complexes are crucial for signal 
amplification.77 Electrostatic attraction between positively-charged CCP and 
negatively charged phosphate groups in DNA/probe-C* plays a vital role in 
bringing CCP and C* into close proximity to meet the FRET distance 
requirement. Different from ideal FRET systems where the distance between 
the donor and the acceptor is fixed, the distance between CCP and C* varies 
due to the dynamic complex structures of CCP/target/probe-C*. Thus, FRET 
between CCP and C* is much more complicated than ideal FRET process. 
Within the macromolecular complexes, there are cross-interaction between 




between CCP and probe-C* favors FRET; whereas, self-interaction among 
CCPs leads to polymer aggregation, which reduces the polymer quantum yield 
in solution. Self-interaction among C* causes dye fluorescence quenching, 
ultimately leading to reduced signal amplification.  
According to this understanding, it is possible to optimize the FRET 
conditions to achieve high signaling emission, such as to increase the donor 
quantum yield (QD), to improve the spectral overlap (J(λ)), to optimize the 
molecular orientation (k), and to shorten the distance between donor/acceptor 
pairs (R0). In addition, it is also important to select donor-acceptor pairs with 
well-matched energy levels to minimize PET, and to develop strategies to 
solve the fluorescence self-quenching of both CCP and C* upon CCP/probe-





MULTICOLOR CONJUGATED POLYELECTROLYTE 
WITH ENERGY TRANSFER BACKBONE FOR VISUAL 
DETECTION OF HEPARIN 
3.1. Introduction  
Heparin is a naturally-occurring sulfated polysaccharide belonging to the 
category of glycosaminoglycans.78 Due to its interaction with diverse proteins, 
heparin plays a significant role in the regulation of various physiological 
processes, such as cell growth and differentiation, inflammatory process, and 
blood coagulation process.79 Heparin has been widely employed as a major 
clinical anticoagulant drug to prevent thrombosis during surgery and to treat 
thrombotic diseases.80,81 This clinical application of heparin is based on its 
unique capability of accelerating the rate at which antithrombin inhibits serine 
proteases in the blood coagulation cascade.80 However, heparin overdose 
could induce thrombocytopenia, which is recognized as one of the most 
catastrophic complications of heparin treatment.82-84 Close monitoring and 
quantification of heparin is of vital importance not only for its regulation in 
the physiological process but also for its clinical application during surgery 
and post-operative therapy period. 
Traditional clinical procedures for heparin quantification rely on the 
measurement of activated clotting time (ACT)85 or activated partial 
thromboplastin time (APTT).86 These indirect methods are not sufficiently 
reliable, accurate, and amenable to clinical settings.87,88 Recently, fluorescent 




synthetic cationic chromophores or chromophore-tethered flexible copolymers 
as heparin receptor.89-91 These assays adopt fluorescence quenching as signal 
output, which is undesirable for heparin quantification and visual detection. 
More recently, a peptide based sensor was reported to show fluorescence 
increase upon interaction with heparin.92 However, the detection window of 
the fluorescence turn-on sensor (0-0.06 U/mL) is out of the clinical range (0.2-
8 U/mL). Development of effective and visual fluorescent assays for heparin 
quantification is in urgent demand, which becomes a challenge in the field of 
chemical and biological sensors.  
A unique platform for construction of chemical and biological sensors has 
been provided by CPEs which combine the optoelectronic properties of π-
conjugated polymers with water-solubility of polyelectrolyte.28,60 In 
comparison with small molecular counterparts, the delocalized electronic 
backbone structure of CPEs allows more rapid intrachain and interchain 
energy transfer.10 In particular, interchain FRET was reported to be more 
efficient than intrachain FRET due to stronger electronic coupling and 
increased transfer dimensionality for interchain vs. intrachain interactions.94-96 
According to this mechanism, a cationic poly(fluorene-alt-1,4-phenylene) 
derivative containing 5 mol% 2,1,3-benzothiadiazole (BT) units (PFBT5%) 
was developed for multi-color sensing.97 In dilute solutions, the polymer emits 
blue. Complex formation between the polymer and oppositely charged DNA 
molecules induces polymer aggregation and increases the local concentration 
of BT units, leading to enhanced interchain contacts and improved electronic 
coupling between optical partners. Under these conditions, energy transfer 




is more efficient than that for isolated chains, and thus green emission 
dominates the solution fluorescence. The aggregation induced blue-to-green 
fluorescence change was subsequently implemented for DNA 
quantification.98,99 Recently, an anionic PPE comprising low energy traps was 
also reported to detect cationic amines.100 To improve the sensitivity and 
broaden the quantification range of these assays, the main challenge is to 
synthesize donor-acceptor CPEs with good water-solubility and high acceptor 
content. 
 
Scheme 3.1. Chemical structures of PFBT5% and PFOBT. 
In this chapter, we design and synthesize a new BT-containing CCP with 
high water-solubility and 20 mol% BT content (PFOBT). The chemical 
structure of PFOBT is shown in Scheme 2.1 along with PFBT5%. The 
optical properties of PFOBT are investigated and compared with PFBT5% to 




effect on the intrinsic BT emission prior to analyte addition. The negatively-
charged sulfated groups of heparin enable the complexation with the polymer 
via electrostatic attractions. As such, a multicolor biosensor for heparin 
detection and quantification can be developed by taking advantage of the 
polymer/heparin complex formation to induce FRET from the fluorene 
fragments to the BT units. Moreover, the optical response of PFOBT to 
heparin and its analogue hyaluronic acid (HA) is compared to probe the effect 
of electrostatic attraction on FRET. The chemical structures of heparin and 
HA are shown in Scheme 3.2. In addition to these investigations, we also show 
that PFOBT can be utilized for naked-eye detection and quantification of 
heparin with the assistance of a hand-held UV lamp. 
 
Scheme 3.2. Chemical structures of heparin and HA. 
3.2. Experiment 
3.2.1. Instruments 
The nuclear magnetic resonance (NMR) spectra were collected on Bruker 
ACF400 (400 MHz). The Element analysis was performed on Perkin-Elmer 
2400 CHN/CHNS and Eurovector EA3000 Elemental Analyzers. Gel 
permeation chromatography (GPC) analysis was conducted with a Waters 
2690 liquid chromatography system equipped with Waters 996 photodiode 




tetrahydrofuran (THF) as the eluent at a flow rate of 1.0 mL/min at 35 °C. 
UV-vis spectra were recorded on a Shimadzu UV-1700 spectrometer. 
Photoluminescence (PL) measurements were carried out on a Perkin Elmer 
LS-55 equipped with a xenon lamp excitation source and a Hamamatsu (Japan) 
928 PMT, using 90 degree angle detection for solution samples. The excitation 
energy at different wavelength was automatically adjusted to the same level by 
an excitation correction file. Freeze drying was performed using Martin Christ 
Model Alpha 1-2/LD. Photographs of the polymer solutions were taken using 
a Canon EOS 400D Digital camera under a hand-held UV-lamp with λmax = 
365 nm. All UV and PL spectra were collected at 24 ± 1 ºC. MilliQ water 
(18.2 MΩ) was used for all the experiments.  
3.2.2. Materials 
All chemical reagents were purchased from Sigma-Aldrich Chemical 
Company, and were used as received. PFBT5%,97 and 2,7-dibromo-9,9'-
bis(6''-bromohexyl) fluorene101 were synthesized according to our previous 
reports. 1,2-bis(2-bromoethoxy)ethane were synthesized according to the 
literature.102 Fresh stock solutions for PFOBT (1 mM), HA (1 mM) and 
heparin (1 mM) were used. Heparin molecular weight is determined by the 
common repeat dimer (644.2 g/mol). The heparin has 170 U/mg, and 1 μM 
heparin corresponds to 0.11 U/mL. 






9,9′-Bis(bromohexyl)-2,7-dibromofluorene (6.5 g, 10 mmol), bis-
(pinacolato)diborane (6.0 g, 24 mmol), KOAc (7.0 g, 70 mmol), and dioxane 
(100 mL) were mixed together in a 250 mL flask. After degassing, 
[Pd(dppf)Cl2] (0.5 g, dppf = 1,1'-bis(diphenylphosphanyl)ferrocene) was 
added. The reaction mixture was kept at 85 °C overnight, and then cooled to 
room temperature. The organic solvent was distilled out, and the residual solid 
was dissolved in dichloromethane and washed with water. After drying with 
Na2SO4, the solvent was distilled out. The crude product was purified by flash 
chromatography using hexanes and dichloromethane (2:1) as the eluent to give 
M1 as a white solid (4.2 g, 59%). 1H NMR (400 MHz, CDCl3, δ ppm): 7.86-
7.77 (m, 2 H), 7.77-7.67 (m, 4 H), 3.25 (t, 4 H, J = 6.8 Hz), 2.08-1.93 (m, 4 H, 
J = 4.2 Hz), 1.64-1.57 (m, 4H, J = 7.2 Hz,), 1.39 (s, 24 H), 1.17-1.13 (m, 4 H), 
1.06-1.02 (m, 4 H), 0.54 (m, 4 H); 13C NMR (100 MHz, CDCl3, δ ppm): 150.3, 
144.1, 134.0, 128.9, 119.7, 84.0, 55.2, 40.1, 34.2, 32.8, 29.2, 27.9, 23.6; 
Element analysis calcd (%) for C37H54B2Br2O4: C 59.71, H 7.31. found: C 
59.42, H 7.29; MS (EI): m/z 744.26 M+. 
3.2.3.2. 2,7-Dibromo-9,9'-bis(2-(2-(2''-bromoethoxy)ethoxy)ethyl)fluorene 
(M2) 
2,7-Dibromofluorene (1.23 g, 5 mmol) was added to a mixture of aqueous 
potassium hydroxide (100 mL, 50 w%), tetrabutylammonium bromide (0.330 
g, 1 mmol), and 1,2-bis(2-bromoethoxy)ethane (13.9 g, 50 mmol) at 75 °C. 
After 15 min, the mixture was cooled to room temperature. After extraction 
with CH2Cl2, the combined organic layers were washed successively with 
water, aqueous HCl (1 M), water, and brine and then dried over Na2SO4. After 




residue was purified by silica gel column chromatography using hexane and 
dichloromethane (1:2) as the eluent, and recrystallized from ethanol and 
CH2Cl2 (5:1) to afford M2 as white needle crystals (1.50 g, 48.0%); 1H NMR 
(400 MHz, CDCl3, δ ppm): 7.54-7.46 (m, 6 H), 3.68 (t, 4 H, J = 6.3 Hz,), 3.39 
(dd, 8 H, J = 4.4 Hz, J = 7.9 Hz), 3.20 (dd, 4 H, J = 3.6 Hz, J = 5.6 Hz), 2.80 (t, 
4 H, J = 7.2 Hz), 2.34 (t, 4 H, J = 7.2 Hz); 13C NMR (100 MHz, CDCl3, δ 
ppm): 150.95, 138.47, 130.69, 126.76, 121.64, 121.23, 71.15, 70.35, 70.04, 
66.90, 51.97, 39.49, 30.90, 30.20; Element analysis calcd (%) for C25H30Br4O4: 
C 42.05 H 4.23. found: C 42.06, H 4.31; MS (EI): m/z 713.89 (M+). 
3.2.3.3. Synthesis of PFOBT0 
M1 (372 mg, 0.5 mmol), M2 (240.67 mg, 0.3 mmol), 4,7-dibromo-2,1,3-
benzothiadiazole (58.79 mg, 0.2 mmol), [Pd(PPh3)4] (5 mg), and potassium 
carbonate (828 mg, 6 mmol) were placed in a 25 mL round-bottomed flask. A 
mixture of water (3 mL) and toluene (5 mL) was added to the flask, and the 
reaction vessel was degassed. The mixture was vigorously stirred at 90 °C for 
24 h and then precipitated into methanol. The polymer was filtered and 
washed with methanol and acetone, and then dried under vacuum for 24 h to 
afford the neutral polymer PFOBT0 (478 mg) as yellow fibers in 90% yield. 
1H NMR (400 MHz, CDCl3, δ ppm): 8.13-7.55 (m, 10.4 H), 3.68 (t, 2.4 H, J = 
6.1 Hz), 3.50-3.24 (m, 11.2 H), 3.21-2.71 (m, 2.4 H), 2.70-2.33 (m, 2.4 H), 
2.30-2.00 (br, 4.0 H), 1.77-1.66 (br, 4.0 H), 1.33-1.16 (m, 8.0 H), 1.03-0.75 (br, 
4.0 H); 13C NMR (100 MHz, CDCl3, δ ppm): 154.35, 151.89, 151.54, 151.36, 
151.01, 149.86, 149.38, 140.78, 140.19, 139.38, 136.57, 136.36, 133.53, 
128.39, 128.04, 126.84, 126.35, 123.97, 121.58, 121.22, 120.26, 71.10, 70.39, 




23.73. Elemental analysis calcd (%) for C42.3H48.8Br3.2O2.4N0.8S0.4: C 58.04, H 
5.62, N 1.28; Found: C 57.92, H 5.69, N 1.15. 
3.2.3.4. Synthesis of PFOBT 
Condensed trimethylamine (2 mL) was added dropwise to a solution of 
PFOBT0 (50 mg) in THF (10 mL) at -78 °C. The mixture was allowed to 
warm to room temperature. The precipitate was redissolved by the addition of 
water (10 mL). After the mixture was cooled to -78 °C, additional 
trimethylamine (2 mL) was added, and the mixture was stirred at room 
temperature for 24 h. After solvent removal, acetone was added to precipitate 
PFOBT (55 mg) as an orange glassy solid in 85% yield. 1H NMR (400 MHz, 
CD3OD, δ ppm): 8.33-7.76 (m, 10.4 H), 3.82-3.73 (br, 2.40 H), 3.55-3.40 (m, 
4.80 H), 3.14-3.00 (m, 28.8 H), 2.88-2.18 (m, 4.80 H), 1.68-1.56 (br, 4 H), 
1.39-1.20 (br, 8 H), 1.15-0.66 (br, 4 H); 13C NMR (100 MHz, CD3OD, δ 
ppm):155.62, 153.60, 153.02, 152.30, 151.79, 151.06, 142.53, 141.84, 141.14, 
140.44, 138.04, 137.81, 134.47, 133.22, 131.74, 129.80, 127.99, 127.51, 
126.13, 125.23, 122.80, 122.44, 121.71, 71.44, 70.79, 68.56, 68.37, 67.75, 
66.95, 65.92, 56.80, 54.90, 53.62, 41.22, 30.35, 26.96, 25.05, 23.72. 
3.3. Results and Discussion 
3.3.1. Synthesis and Characterization 
CCPs with high BT content are desirable since they offer high sensitivity 
for analyte detection.103 However, high BT content polymers were found to 
show undesired BT-emission in aqueous solution prior to analyte addition.98 
Synthetic efforts are thus focused on the optimization of polymer structure in 




Scheme 3.3 depicts the synthetic approach towards PFOBT. The 
dioxaborolane monomer, 2,7-bis[9,9'-bis(6''-bromohexyl)-fluorenyl]-4,4,5,5-
tetramethyl-[1.3.2]dioxaborolane (M1), was synthesized in 59% yield by 
heating a mixture of 2,7-dibromo-9,9'-bis(6-bromohexyl) fluorene and 
bis(pinacolao)diborane with KOAc in dioxane at 85 °C for 12 h. In a two-
phase basic deprotonation condition, 2,7-dibromofluorene was alkylated with 
1,2-bis(2-bromoethoxy)ethane to afford 2,7-dibromo-9,9'-bis(2-(2-(2-
bromoethoxy)ethoxy)ethyl)fluorene (M2) in 48% yield. The correct structures 
of M1 and M2 were affirmed by NMR, elemental analysis and mass 
spectrometry. The Suzuki cross-coupling mediated copolymerization of M1, 
M2 and 4,7-dibromo-2,1,3-benzothiadiazole at a feed ratio of 0.5 : 0.3 : 0.2 
provided the neutral statistical random copolymer (PFOBT0). The number-
average molecular weight and polydispersity of PFOBT0 are 11,000 and 3.0 
respectively, determined by GPC using THF as the solvent and polystyrene as 
the standard. Further treatment of PFOBT0 with trimethylamine in THF/water 
yielded the BT-containing CCP (PFOBT).  
The chemical structures of PFOBT0 and PFOBT were determined by 1H 
and 13C NMR spectroscopies. According to the 1H NMR spectrum of PFOBT0, 
the ratio of the integrated area of the signal at 3.68 ppm (-OCH2CH2Br from 
M2) to that of the signal at 2.18 ppm (-CH2(CH2)5Br from M1) is identical to 
0.60. This indicates that the BT content in the polymer is the same as the feed 
ratio (20%), which is further affirmed by the elemental analysis of PFOBT0. 
The ratio of the integrated areas for -CH2CH2X (X = Br, N(CH3)3) and -
CH2CH2N(CH3)3 in the 1H NMR spectra of PFOBT shows that the degree of 




solvents, including dimethyl formamide (DMF), dimethyl sulphoxide (DMSO), 
methanol and water. Noteworthy is that the water-solubility of PFOBT is 12 
mg/mL at 24 ± 1 ºC. The high water-solubility of PFOBT results from the 
high charge density and the oligo(ethylene oxide) side chains.34 
 
Scheme 3.3. Synthetic route of PFOBT. Reagents and conditions: (i) 
bis(pinacolato)diborane, [Pd(dppf)Cl2], KOAc, dioxane, 85 °C, 12 h; (ii)1,2-
bis(2-bromoethoxy)ethane, TBAB, KOH/H2O, 75 °C, 15 min; (iii) [Pd(PPh3)4], 
K2CO3, toluene/H2O, 90 °C, 24 h; (iv) THF/H2O, NMe3, 24 h. 
3.3.2. Optical Properties 
The UV-vis absorption and PL spectra of PFOBT in water are depicted in 
Figure 3.1. The concentration of PFOBT based on repeat unit ([RU]) is 3 μM. 
[RU] has a molecular weight of 1065.7 g/mol, which includes 1 mol 
(trimethylammonium)hexyl-substituted fluorene, 0.6 mol 




BT. The absorption spectrum of PFOBT exhibits a maximum at 375 nm 
corresponding to the fluorene segments and a characteristic band ranging from 
426 to 520 nm corresponding to the BT units.98 The emission spectrum of 
PFOBT shows a maximum at 415 nm with almost no obvious emission band 
in 500-650 nm region as an indication of inefficient FRET in dilute solution.98  
 
Figure 3.1. Normalized absorption (a) and PL spectra (b) of PFOBT at [RU] 
= 3 μM in water (excitation at 365 nm).  
Figure 3.2 shows the normalized PL spectra of PFOBT and PFBT5% 
with [RU] = 3 μM or 60 μM in 2 mM PBS (pH = 7.4) upon excitation at 365 
nm. For PFBT5%, the BT emission band ranging from 500 to 650 nm is 
visible at both concentrations. The higher ratio of the green/blue emission 
intensity at [RU] = 60 μM as compared to that at [RU] = 3 μM indicates that 
aggregation of PFBT5% occurs at elevated concentrations due to its poor 
water-solubility.100 On the contrary, the PL spectra of PFOBT is dominated 
by the blue emission, and the BT emission is weak at both [RU] = 3 μM and 
60 μM. This originates from the high water-solubility of PFOBT that inhibits 
polymer aggregation. The difference in the concentration-dependent BT 
emission between PFOBT and PFBT5% highlights the importance of 


































polymer structural design, which makes PFOBT more suitable for heparin 
detection and quantification than PFBT5% does.  
 
Figure 3.2. Normalized PL spectra of PFOBT and PFBT5% at [RU] = 3 μM 
(a) and [RU] = 60 μM (b) in 2 mM PBS buffer at pH = 7.4 (excitation at 365 
nm).  
3.3.3. Aggregation-Induced FRET 
Heparin titration experiments were conducted at [RU] = 60 μM in 2 mM 
PBS (pH = 7.4). The heparin concentration was calculated using sugar dimer 
as the RU. Figure 3.3a shows the changes in the PL spectra of PFOBT upon 
addition of heparin from 0 to 50 μM at intervals of 2 μM. As [heparin] 
increases, the orange emission band at 595 nm progressively grows at the 
expense of the blue emission band at 415 nm. An isosbestic point is observed 
at 515 nm. This transformation in the PL spectra of PFOBT reflects 

































gradually-increased FRET from the fluorene segments (energy donor) to the 
BT units (energy acceptor) upon PFOBT/heparin complex formation. At 
[heparin] = 48 μM, the intensity of the orange emission band reaches its 
maximum, indicating the analyte-receptor saturation. At this point, the 
concentration of negative charges from heparin is 192 μM, while the 
concentration of positive charges from PFOBT is 190 μM. The nearly 
identical concentration of opposite charges at saturation is consistent with the 
previous reports that charge balance is essential for complexation between 
oppositely charged polymers and analytes based on electrostatic 
interactions.97-99  
 
     
Figure 3.3. (a) PL spectra of PFOBT at [RU] = 60 μM in 2 mM PBS at pH = 
7.4 in the presence of heparin with concentrations ranging from 0 to 50 μM at 
intervals of 2 μM (excitation at 365 nm); (b) Changes in the fluorescent color 
of the corresponding solution at intervals of 4 μM under a hand-held UV-lamp 
with λmax = 365 nm. 





















Changes in the PL spectra of polymer solution could be monitored by 
naked-eye under a portable UV-lamp with λmax = 365 nm. Figure 3.3b shows 
heparin-induced solution fluorescence change with [heparin] = 0 to 48 M at 
intervals of 4 M. The color of solution fluorescence gradually transfers from 
blue to orange with increasing [heparin]. At the low [heparin] range (0-16 μM), 
the solution fluorescent color appears blue; at the moderate [heparin] range 
(20-28 μM), the solution fluorescent color appears pink; while at the high 
[heparin] range (> 28 μM), the solution fluorescent color appears orange. The 
distinguishable color at different heparin concentrations should benefit from 
the similar rate of countercurrent fluorescence changes in the fluorene 
emission band at 415 nm and the BT emission band at 595 nm. As a result, 
naked-eye quantification of heparin is feasible using the CCP-based heparin 
assay. Since the therapeutic dosing level of heparin ranges from 0.2 to 8 U/mL 
(1.8-72 μM), depending on the clinical treatment,105 the range of heparin 
concentration obtained by this assay (0-48 μM) is practical.  
To understand the importance of electrostatic attraction in the heparin-
induced BT emission, similar experiments were performed with HA, an 
analogue of heparin. Heparin has four negatively charged side groups per RU, 
while HA possesses only one negatively charged group per RU (shown in 
Scheme 3.2), implying a weaker electrostatic attraction between HA and 
PFOBT than that between heparin and PFOBT. Upon addition of HA into the 
PFOBT solution at [RU] = 60 μM in 2 mM PBS, very small variations in the 
PL spectra of PFOBT are observed. The normalized PL spectra of PFOBT at 
[heparin] or [HA] = 44 μM are shown in Figure 3.4. A 110-fold higher 




presence of HA is observed, indicating the highly-preferred response of 
PFOBT to heparin over HA. This selectivity is associated with much stronger 
electrostatic attraction between heparin and PFOBT in contrast to that 
between HA and PFOBT, which consequently induces more compact polymer 
aggregation in the presence of heparin.102 Within the tested [HA] range, the 
fluorescent color of PFOBT/HA mixture remains blue, affording a facile way 
to distinguish heparin from HA by naked eye as demonstrated in the inset of 
Figure 3.4. On the other hand, it should be metioned that chitosan can aslo 
induce the intensity increase at BT emission; however, its intensity at 
[chitosan] = 44 μM is 50% of that at heparin. 
 
Figure 3.4. Normalized PL spectra of PFOBT at [RU] = 60 μM in the 
presence of [heparin] or [HA] = 44 μM in 2 mM PBS at pH = 7.4 (excitation 
at 365 nm). The inset shows the corresponding fluorescent color under a hand-
held UV-lamp with λmax = 365 nm. 
3.3.4. Heparin Quantification 
To demonstrate heparin quantification using the CCP-based assay, 
changes in the PL spectra of PFOBT in Figure 3.3a are correlated to [heparin]. 




















To eliminate the discrepancy across different instruments and optical 
collection conditions, φ was defined as: 
φ = (I – I0)/I0                                        (Eq. 2.1) 
Where, I and I0 are the intensities at 595 nm in the presence and absence 
of heparin, respectively. Figure 3.5 shows φ as a function of [heparin] together 
with its linear trendline, which has a slope of 0.19 μM-1. The well overlap 
between the original data and the linear trendline in the range of 0 to 48 μM 
proves the validity of heparin concentration calibration using the CCP-based 
assay. The departure from the linear trendline at [heparin] > 48 μM is caused 
by receptor saturation as aforementioned. This indicates the upper detection 
limit for heparin is 48 μM using a PFOBT solution with [RU] = 60 μM.  
 
Figure 3.5. φ as a function of [heparin] and its linear trendline at [RU] = 60 
μM in 2 mM PBS at pH = 7.4. The data are based on the average of three 
independent experiments. 
To examine the low detection limit of the optical response, experiments 
were carried out using a dilute PFOBT solution with [RU] = 3 μM in 2 mM 
PBS. As shown in the inset of Figure 3.6, with increasing [heparin] at intervals 
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of 30 nM, a progressive emission intensity increase at 595 nm is observed. 
Figure 3.6 also shows  as a function of [heparin] together with its linear 
trendline. Reducing the interval [heparin] to 3 nM only leads to a slight 
intensity decrease at 415 nm with almost no emission intensity increase at 595 
nm. Addition of heparin with concentrations at intervals of 3 nM to PFOBT at 
[RU] = 0.3 μM in 2 mM PBS also cannot bring in any intensity increase at 595 
nm. These data indicate that further decreasing the concentration of PFOBT 
or heparin is unable to induce efficient FRET, owing to the deficiency of 
polymer aggregation as compared to the assays operated at high 
concentrations. As a result, the low detection limit for the CCP-based assay for 
heparin quantification is close to [heparin] = 30 nM. 
 
Figure 3.6. φ as a function of [heparin] and its linear trendline at [RU] = 3 μM 
in 2 mM PBS at pH = 7.4. The inset shows the corresponding PL spectra of 
PFOBT at [RU] = 3 μM in 2 mM PBS at pH = 7.4 upon addition of heparin 
with concentrations ranging from 0 to 180 nM at intervals of 30 nM. The data 
are based on the average of three independent experiments. 
3.4. Conclusion 
A multicolor biosensor for heparin detection and quantification was 
developed on the basis of the fluorescence change of a water-soluble BT-
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containing CCP. The operation mechanism takes advantage of strong 
electrostatic attraction between the CCP and heparin. Upon polymer/heparin 
complexation, orange emission is induced by FRET from the fluorene 
segments to the BT units in the aggregated state. Good affinity and selectivity 
of PFOBT for heparin over a similar polysaccharide (HA) lead to an obvious 
difference in the fluorescence change of PFOBT, which can be easily 
distinguished by naked eye. The linear response of the orange-band emission 
vs. heparin concentration allows efficient and accurate heparin quantification 
in a range of 30 nM (3.3 μU/mL) to 48 μM (5 U/mL). This detection range is 
significantly borader than other fluorescent probes, such as tripodal boronic 
acid (0.2-9 U/mL),90 and chromophore-tethered copolymer (0.075-0.55 
U/mL).91 In addition, adjustment of heparin quantification range for a specific 
application could be realized through varying polymer concentration. The 
most significant advantage of this assay is the feasibility of naked-eye 
detection and quantification of heparin in real-time. The assay reported herein 








CONJUGATED POLYELECTROLYTE FOR VISUAL 
DETECTION OF DOUBLE-STRANDED DNA 
4.1. Introduction 
Facile and reliable methods for detection of nucleic acids are of scientific 
importance and economic interest due to their vital applications in 
pharmaceutics, clinical diagnosis, forensic analysis and antiterrorism.106-108 
Since DNA is rarely present in single-stranded form either naturally or after 
polymerase chain reaction (PCR) amplification, probes that generate sensitive 
optoelectronic signatures toward dsDNA are under extensive 
investigations.109-112 A new platform for dsDNA detection has been provided 
by CPEs, which integrate the light-harvesting properties of π-conjugated 
polymers with the electrostatic behaviors of polyelectrolytes.10 CPEs have 
been employed in conjunction with chromophore-labeled PNA or DNA probes 
for DNA hybridization detection.25 Upon excitation of CPEs, the light 
emission characteristic of signaling chromophore is more intense in the 
presence of complementary DNA relative to that in the presence of non-
complementary DNA.3 Despite its simplicity, this method requires labeled 
probes and has obvious background signals due to nonspecific interaction 
between CPEs and the probe prior to target addition.7 CPEs that could 
specifically response to label-free dsDNA are highly desirable in view of the 




Difficulties in using CPEs for direct dsDNA detection mainly arise from 
the ubiquitous nonspecific interactions (electrostatic and hydrophobic 
interactions) between the polymer and a large amount of biological and 
nonbiological substances.10 However, the conformation-dependent 
colorimetric behaviors of cationic PT have been successfully applied for label-
free DNA hybridization detection.52 This assay takes advantage of different 
electrostatic attractions and conformations of the polymer in the presence of 
dsDNA and ssDNA, giving rise to distinguishable colorimetric signal 
outputs.115 On the other hand, the optical properties of PTs were reported to be 
sensitive to the environment. Variations in solution temperature 13,116 or ionic 
strength and the presence of charged biomolecules in solution could easily 
disturb the polymer absorption and emission,10 which indicates that cationic 
PT is more suitable for detection of pure DNA samples in solution. However, 
clinical nucleic acid samples often exist in biological media such as blood and 
PCR solutions,107 wherein different proteins with various charges are present 
to interact with CPEs. The design of CPEs with precise optical signatures 
toward label-free dsDNA in biological media hence remains challenging. 
Asymmetric cyanines, including thiazole orange (TO) and oxazole yellow 
(OY), are intercalating dyes that feature a substantial fluorescence 
enhancement upon dsDNA intercalation.118 The working principle is that the 
nonradiative decay of photoexcited cyanine dyes is regulated by the rotation 
rate of the central methine which would be greatly reduced within the 
constrictive dsDNA environment. Asymmetric cyanines have been extensively 
used in reticulocyte analysis to stain residual RNA of blood cells 119 or DNA 




consideration of the high affinity of TO toward dsDNA and its low-energy 
emission, introduction of TO into CPE systems should be an effective method 
to combine the accurate dsDNA discriminability of TO with the optical 
amplification of CPE, leading to a new generation of dsDNA-responsive CPEs 
with light-up signatures.  
In this chapter, we show an intercalating dye harnessed CCP that can be 
utilized for naked-eye recognition of dsDNA in biological media. We start 
with the design and synthesis of TO-tethered cationic poly(fluorene-alt-
phenylene) (PFPTO) comprising 5 mol% TO content. This TO component 
ratio is chosen on the basis of our previous studies that 5 mol% content of 
energy acceptor units in PFP is sufficient to induce visible acceptor emission 
through FRET.97 The optical properties of PFPTO in aqueous solutions are 
studied in comparison with free TO and PFP. The fluorescence response of 
PFPTO toward DNA in buffer is investigated and discussed in details by 
selective excitation of the polymer backbone or TO. To highlight the 
advantages of the linked donor-acceptor architecture of PFPTO, parallel 
experiments are conducted for the free TO/PFP system. Finally, we show that 
PFPTO allows real-time naked-eye recognition of dsDNA in serum.  
4.2. Experiment 
4.2.1. Instruments 
The same instruments as those in Chapter 2 are used for the experiments.  
4.2.2. Materials 
HPLC-purified DNA oligonucleotides (5′-ATC TTG ACT ATG TGG 




Research Biolabs, Singapore. Fetal Bovine Serum was purchased from 
HyClone. 10×PBS buffer with pH = 7.4 (ultrapure grade) is commercial 
product of 1st BASE, Sinagpore. MilliQ water (18.2 MΩ) was used to prepare 
the buffer solutions from the 10×PBS stock buffer. 1×PBS contains 137 mM 
NaCl, 2.7 mM KCl, 10 mM Na2HPO4, and 1.8 mM KH2PO4. Fisher brand 
regenerated cellulose dialysis tubing with 3.5 kDa molecular weight cutoff 
was used for the polymer dialysis. Other chemical reagents were purchased 
from Sigma-Aldrich chemical company, and were used as received. N-(4-
iodobuty)-lepidine and S,3-dimethylbenzothiazole-2-thiol were synthesized 
according to the previous literature.122 2,7-Dibromo-9,9'-bis(6''-(N,N-
dimethylamino)hexyl)-fluorene and poly[(9,9'-bis(6''-(N,N,N,-
trimethylammonium)-hexyl)fluorene-alt-1,4-phenylene) diiodide] were 
synthesized according to our previous report.25 
4.2.3. Synthesis 
4.2.3.1. N-(4-iodobutyl)thiazole orange (1) 
A total of N-(4-iodobuty)-lepidine (453 mg, 1 mmol) and S,3-
dimethylbenzothiazole-2-thiol (322 mg, 1 mmol) were suspended in 10 mL of 
absolute ethanol with slight heating at 65 °C for 5 min. Triethylamine (420 μL, 
3 mmol) was added dropwise to this solution, and the reaction mixture was 
immediately turned to deep red. The reaction was stirred at room temperature 
for additional 2 h. Then it was poured into diethyl ether to precipitate the raw 
product, which was followed by recrystallization from 
methanol/dichloromethane to give 3 (420 mg) as a red solid in 70% yield. 1H 




H, J = 6.50 Hz), 8.23-8.01 (d, 1 H, J = 8.74 Hz), 8.00 (dd, 2 H, J = 8.27, 17.36 
Hz), 7.67-7.54 (m, 1 H), 7.67-7.54 (m, 1 H), 7.50-7.31 (m, 2 H), 6.91 (s, 1 H), 
4.62 (t, 2 H, J = 6.91 Hz), 4.33 (t, 2 H, J = 5.86 Hz), 4.00 (s, 3 H), 2.09-1.71 
(m, 4 H). 13C NMR (100 MHz, d6-DMSO, δ ppm): 148.65, 144.30, 140.54, 
137.02, 133.39, 129.29, 126.93, 125.92, 124.65, 124.30, 123.95, 122.95, 
118.16, 113.11, 107.96, 88.28, 53.10, 33.93, 29.95, 7.69. Element analysis 
calcd. (%) for C22H22I2N2S: C 44.02 H 3.69, N 4.67; found: C 44.26, H 3.78, 
N 4.56.  
4.2.3.2. Poly(9,9'-bis(6''-(N,N-dimethylamino)hexyl)-fluorene-alt-phenylene) 
(2) 
1,4-Phenyldiboronic acid (50 mg, 0.30 mmol), 2,7-dibromo-9,9-bis(6-
(N,N-dimethylamino)hexyl)-fluorene (173 mg, 0.30 mmol), Pd(PPh3)4 (5 mg) 
and potassium carbonate (500 mg, 3.60 mmol) were placed in a 10 mL round 
bottom flask. A mixture of water (2 mL) and toluene (3 mL) was added to the 
flask and the reaction vessel was degassed. The mixture was vigorously stirred 
at 95 °C for 12 h, and then precipitated into methanol. The polymer was 
filtered and washed with methanol and acetone, and then dried under vacuum 
for 24 h to afford 2 (125 mg) as a white glassy solid in 85% yield. 1H NMR 
(400 MHz, CDCl3, δ ppm): 7.94-7.43 (m, 10 H), 2.15 (br, 12 H), 1.87 (br, 8 H), 
1.31 (br, 4 H), 1.13 (br, 8 H), 0.80 (br, 4 H). 13C NMR (100 MHz, CDCl3, δ 
ppm): 151.65, 140.43, 140.13, 139.62, 127.55, 125.98, 121.41, 120.11, 59.72, 
55.24, 45.35, 40.41, 29.98, 27.53, 27.13, 23.89. 




A mixture of 2 (60 mg, 0.121 mmol, 0.242 mmol –N(CH3)2) and 3 (3.35 
mg, 0.006 mmol) in THF (10 mL) was vigorously stirred at reflux for 48 h. 
The reaction mixture was precipitated in methanol for three times to afford 3 
(55 mg) as red fibers in 90% yield. 1H NMR (400 MHz, CDCl3, δ ppm): 8.12-
7.30 (m), 6.70 (s), 3.74 (t), 3.34 (s), 1.88 (br), 1.78 (br), 1.30 (br), 1.13 (br), 
0.81 (br). 13C NMR (100 MHz, CDCl3, δ ppm): 151.67, 140.45, 140.16, 
139.62, 127.60, 126.00, 121.45, 120.15, 59.76, 55.27, 45.38, 40.45, 30.10, 
27.58, 27.72, 27.15, 23.79. 
4.2.3.4. Synthesis of PFPTO 
Methyl iodide (1 mL) was added to 3 (50 mg) in THF (5 mL) and DMF (5 
mL). After stirring at room temperature for 10 minutes, methanol (5 mL) was 
added. After 48 h, THF and methanol was removed at reduced pressure. The 
residual solution was then poured into acetone to give the crude product (58 
mg) as red powders. The product was further purified by dialysis against Mill-
Q water using a 3.5 kDa molecular weight cutoff dialysis membrane for 3 days 
in order to further remove any residual TO (1). After freeze-drying, PFPTO 
(52 mg) was obtained in 88% yield as red fibers. 1H NMR (400 MHz, d6-
DMSO, δ ppm): 8.28-7.33 (m), 3.0 (br), 2.84 (s), 2.37 (br), 1.38 (br), 0.97 (br). 
13C NMR (100 MHz, d6-DMSO, δ ppm): 152.42, 140.85, 140.32, 139.72, 
129.40, 126.82, 121.93, 66.30, 56.11, 55.50, 53.21, 51.10, 36.87, 31.86, 29.78, 




4.3. Results and Discussion  
4.3.1. Synthesis and Characterization 
The TO-tethered CCP was synthesized using a postpolymerization 
strategy. TO was incorporated into the neutral conjugated polymer through 
quaternization, which circumvented the possible structural damage of TO 
during the reaction processes.118 N-(4-iodobutyl)thiazole orange (1), the TO 
linker, was prepared by reacting N-(4-iodobuty)-lepidine with S,3-
dimethylbenzothiazole-2-thiol in ethanol using triethylamine as catalyst 
(Scheme 4.1).123 The correct chemical structure of 1 was affirmed by NMR 
and elemental analysis.  
 
Scheme 4.1. Synthesis of TO (1). Conditions and reagents: triethylamine, 
ethanol, room temperature.  
Scheme 4.2 depicts the synthetic route toward the cationic TO-tethered 
PFP (PFPTO). 1,4-Phenyldiboronic acid was polymerized with 2,7-dibromo-
9,9-bis(6-(N,N-dimethylamino)hexyl)fluorene under a palladium-mediated 
Suzuki cross-coupling reaction condition to afford the corresponding neutral 
precursor, poly(9,9-bis(6-(N,N-dimethylamino)hexyl)-fluorene-alt-phenylene) 
(2). The number-average molecular weight and polydispersity of 2 are 12000 
and 2.6, respectively, determined by GPC using THF as the solvent and 
polystyrenes as the standard. Quaternization of 2 with 1 was performed by 




where the feed ratio of 1 to the RU of 2 was fixed at 5:100. Polymer 3 was 
purified by repetitive precipitation of the THF solution of 3 into methanol. 
Since 1 is soluble in methanol, this precipitation step is propitious to wash 
away the unreacted 1.  
 
Scheme 4.2. Synthesis of PFPTO. Conditions and reagents: (i) 1,4-
phenyldiboronic acid, [Pd(PPh3)4], K2CO3, toluene/H2O, 95 °C, 12 h; (ii) 
iodomethane, THF/DMF, room temperature, 48 h; (iii) 1, THF, reflux, 48 h. 
The 1H NMR spectra of 2 and 3 are shown in Figure 4.1. Polymer 2 has 
no resonance signals in the region of 3-4 ppm. The singlet peak a at 3.23 ppm 
and the triplet peak b at 3.74 ppm in the NMR spectrum of polymer 3 are 
assigned to the proton resonance signals of –N(CH3)2, and -N(CH2)3CH2N-, 
respectively, indicating the successful attachment of TO to 2. The ratio of the 
integrated area of peak a to that of peak b is identical to 3. In addition, the 
ratio of the integrated area of peak b to that of the peak at 1.86 ppm (the 
resonance of protons next to the 9-position of fluorene units) is close to 0.015. 
These data indicate that the TO content in 3 is ~3 mol%. The quaternization 




for the synthesis of homodimeric monomethine cyanine dyes through 
quaternization.124,125 Further quaternization of the tertiary amine groups in 3 
with iodomethane in THF/dimethylformamide (DMF) gave the target polymer 
PFPTO. This polymer was purified by dialysis against Mill-Q water using a 
3.5 kDa molecular weight cutoff dialysis membrane for 3 days. The chemical 
structure of PFPTO was characterized by NMR spectra. Poly[(9,9-bis(6-
(N,N,N,-trimethylammonium)-hexyl)fluorene-alt-1,4-phenylene) diiodide] 
(PFP) was also synthesized by quaternization of 2 with iodomethane under 
similar conditions.  
 
Figure 4.1. 1H NMR spectra of 2 and 3. 
4.3.2. Optical Properties 
The optical properties of PFPTO in water were studied and compared 
with those of PFP and 1. Figure 4.2a shows the absorption spectra of PFPTO, 
PFP and 1. The concentrations of PFPTO and PFP are 1 μM based on 
fluorene-phenylene as RU, while the concentration of 1 is 0.3 μM. PFP and 1 
have the absorption maxima at 372 nm and 495 nm, respectively.  























Figure 4.2. (a) UV absorption spectra of PFPTO and PFP at [RU] = 1 μM, 
and [1] = 0.3 μM; (b) Normalized PL spectra of PFPTO and PFP upon 
excitation at 370 nm. 
Two well-defined absorption bands at 375 and 505 nm are observed for 
PFPTO. The absorption band centered at 375 nm stems from the conjugated 
backbone of PFPTO; while the absorption band with a maximum at 505 nm 
corresponds to the TO side chain. The 10 nm red-shift in TO absorption 
maximum of PFPTO relative to that of 1 indicates the environmental 
difference for polymer bound TO and free TO.126,127 In addition, comparison 
of the maximum absorbance of TO for PFPTO and 1 implicates that the TO 
molar content in PFPTO is ~0.03, which coincides well with the NMR result. 
Figure 4.2b shows the normalized photoluminescence (PL) spectra of PFPTO 












































and PFP. The emission maximum of PFPTO is 417 nm, which is similar to 
that of PFP at 415 nm. The absence of TO emission in the PL spectrum of 
PFPTO indicates that the free-rotation of TO maintains within PFPTO. 
Furthermore, the emission band of PFP ranging from 390 to 550 nm overlaps 
well with the absorption band of 1 ranging from 375 to 550 nm, showing the 
feasibility of FRET from the conjugated backbone of PFPTO to the TO side 
chain.  
4.3.3. Fluorescence Response toward DNA 
To investigate the fluorescence response of PFPTO toward DNA, DNA 
titration experiments were performed by gradually addition of ssDNA or 
dsDNA into PFPTO solutions at [RU] = 2 μM in 1×PBS (pH = 7.4). The TO 
intrinsic fluorescence and the FRET-induced TO fluorescence in the presence 
of DNA were monitored by selective excitation of PFPTO at 490 and 370 nm, 
respectively. Comparison of TO emission upon excitation at these two 
wavelengths reveals how the light-harvesting conjugated backbone of PFPTO 
affects the TO fluorescence in response to DNA. The ssDNA was selected 
with a typically-random sequence of 5′-AGC ACC CAC ATA GTC AAG AT-
3′, and dsDNA was obtained through hybridization of the ssDNA with its 
complementary strand. The tested DNA concentration based on strand varied 
from 0 to 8.4 nM at intervals of 1.2 nM upon each addition.  
4.3.3.1. Intrinsic TO Fluorescence  
Figure 4.3a shows the PL spectra of PFPTO/dsDNA solution upon direct 
excitation of TO at 490 nm. In the absence of dsDNA, the TO emission 




dsDNA, an emission peak with a maximum at 535 nm appears as a result of 
TO intercalation into dsDNA. With increasing [dsDNA], the TO emission 
grows progressively, which is followed by saturation at [dsDNA] = 8.4 nM. 
This indicates that the intercalated TO increases with [dsDNA] until it reaches 
equilibrium.25 At the saturation point, the TO emission intensity is 7.8 a.u., 
which is ~10-fold more intense as compared to that in the absence of dsDNA.  
 
Figure 4.3. PL spectra of PFPTO at [RU] = 2 μM in the presence of (a) 
dsDNA with [DNA] varying from 0 to 8.4 nM at intervals of 1.2 nM, and (b) 
dsDNA or ssDNA with [DNA] = 8.4 nM in 1×PBS at pH = 7.4, excitation at 
490 nm. 
Figure 4.3b shows the PL spectra of PFPTO upon excitation at 490 nm in 
the presence of ssDNA or dsDNA at [DNA] = 8.4 nM. The TO emission 
spectrum is broad and the fluorescence intensity at the emission maximum 





























spectrum and the weak TO fluorescence in the presence of ssDNA implicates 
that complexation between PFPTO and ssDNA could possibly lead to TO 
aggregation.128 As a result, these data indicate that the intercalating ability of 
TO toward dsDNA remains within PFPTO.  
 
Figure 4.4. PL spectra of PFPTO at [RU] = 2 μM in the presence of (a) 
dsDNA with [dsDNA] varying from 0 to 8.4 nM at intervals of 1.2 nM, and (b) 
dsDNA or ssDNA with [DNA] = 8.4 nM in 1×PBS at pH = 7.4, excitation at 
370 nm.  
4.3.3.2. FRET-Induced TO Fluorescence  
Figure 4.4a depicts the PL spectra of PFPTO/dsDNA upon excitation at 
370 nm. The TO fluorescence is mainly attributed to FRET from the 
conjugated backbone of PFPTO to TO, since there is no obvious absorption 





























emission of PFPTO at 420 nm gradually decreases in intensity, while the TO 
emission at 535 nm significantly increases owing to the intercalation-enhanced 
TO emission and the subsequent FRET from the conjugated backbone to TO. 
At [dsDNA] = 8.4 nM where the TO intercalation saturates, the TO emission 
intensity reaches 150 a.u.. Figure 4.4b compares the optical response of 
PFPTO toward dsDNA against ssDNA at [DNA] = 8.4 nM upon excitation at 
370 nm. While the PL intensities at 420 nm are close for PFPTO/dsDNA and 
PFPTO/ssDNA complexes, the intensity of TO emission for PFPTO/ssDNA 
at 545 nm is 42 a.u., which is lower than that for PFPTO/dsDNA (150 a.u.).  
4.3.3.3. Signal Amplification 
To illustrate the effect of energy transfer on TO emission in the presence 
of DNA, the TO emission intensities upon excitation of PFPTO at 370 and 
490 nm are compared. To eliminate the disturbance of background 
fluorescence, ΔI is defined as: 
DNA 0I I I                                         (Eq.3.1) 
where IDNA and I0 are the TO emission intensities in the presence and 
absence of DNA, respectively. Figure 4.5 summarizes ΔI as a function of 
[DNA] upon excitation of PFPTO at 370 and 490 nm, respectively. At each 
[DNA], ΔI for the curves upon excitation of PFPTO at 370 nm is substantially 
larger than that upon direct excitation of TO at 490 nm. This observation 





The largest difference in TO emission intensity is observed at [DNA] = 
8.4 nM where the optical response of PFPTO toward DNA saturates. At this 
point, ΔI upon excitation at 370 nm is 135 and 27 a.u. in the presence of 
dsDNA and ssDNA, respectively; while ΔI upon excitation at 490 nm is 7 and 
1.2 a.u. in the presence of dsDNA and ssDNA, respectively. It is obvious that 
the fluorescence difference between PFPTO/dsDNA and PFPTO/ssDNA 
upon excitation of the polymer backbone (104 a.u.) is substantially larger than 
that upon direct excitation of TO (6 a.u.). The enhanced fluorescence contrast 
facilitates naked-eye discrimination of dsDNA from ssDNA.  
 
Figure 4.5. ΔI as a function of [DNA] upon excitation of PFPTO at 370 
(squares) or 490 nm (circles). [RU] = 2 μM in 1×PBS at pH = 7.4.  
4.3.4. Comparison with Free TO/PFP System 
To compare PFPTO with the free TO/PFP system, PL spectra for 
solutions containing 2 μM PFP, 0.06 μM 1, and 8.4 nM dsDNA or ssDNA in 
1×PBS at pH = 7.4 were collected and the results are shown in Figure 4.6. 
This component ratio simulates the condition where the fluorescence response 
of PFPTO toward DNA saturates. Upon excitation at 490 nm, the intrinsic TO 



















emission intensity at 535 nm is increased by 10-fold and 1.8-fold in the 
presence of dsDNA and ssDNA, respectively, as compared to that in the 
absence of DNA (Figure 4.6a).  
 
Figure 4.6. PL spectra for solutions of TO/PFP at [RU] = 2 μM and [TO] = 
0.06 μM in the absence and presence of dsDNA or ssDNA with [DNA] = 8.4 
nM in 1×PBS at pH = 7.4. Excitation at 490 nm (a) and 370 nm (b).  
The response of free TO to DNA is similar to that of PFPTO upon 
excitation at 490 nm, suggesting that TO intercalation in both cases are similar. 
The higher absolute TO emission intensities in the presence of DNA for 
PFPTO relative to those for free TO/PFP should originate from the additional 
conformation restriction for the covalently-linked TO upon PFPTO and DNA 
complexation. On the other hand, the maximum emission intensities of TO 








































upon excitation of PFP at 370 nm are 32 and 22 a.u. in the presence of dsDNA 
and ssDNA, respectively. The PFP-sensitized TO emission intensities are 
much lower than those obtained for PFPTO (Figure 4.4b). This phenomenon 
implies that more efficient FRET occurs for PFPTO relative to that for free 
TO/PFP, leading to the superior discriminability of dsDNA from ssDNA for 
PFPTO.  
 
Figure 4.7. PL spectra for solutions of TO/PFP at [RU] = 2 μM and [TO] = 
0.06 μM (a), and PFPTO at [RU] = 2 μM (b) in the absence (solid line) and 
presence (dashed line) of dsDNA at [DNA] = 8.4 nM in 2×PBS at pH = 7.4 
upon excitation at 370 nm.  
To probe the origin of the higher TO emission for PFPTO relative to that 
of free TO/PFP, similar experiments were conducted in 2×PBS at pH = 7.4 
where the ionic strength is twice that of 1×PBS. Figure 4.7 shows the PL 


























= 0.06 μM in the absence and presence of dsDNA at [dsDNA] = 8.4 nM upon 
excitation at 370 nm. In the presence of dsDNA, the FRET-induced TO 
emission for TO/PFP solution is much weaker as compared to that obtained in 
1×PBS (Figure 4.7a vs Figure 4.6b), while the change in buffer almost has no 
obvious effect on the FRET-induced TO emission for PFPTO (Figure 4.7b vs 
Figure 4.4b). 
These results indicate that PFPTO is more resistant to environmental 
variations as compared to that for free TO/PFP. On the other hand, it is 
noteworthy that the increase in ionic strength has no obvious effect on the 
intrinsic TO emission for PFPTO and free TO/PFP upon excitation at 490 nm 
in the presence of 8.4 nM dsDNA. The inhibited FRET for free TO/PFP with 
increased ionic strength is similar to that for fluorescein-labeled DNA and 
PFP, where the weakened PFP-sensitized fluorescein emission at elevated 
ionic strength is ascribed to the increased donor-acceptor distance.25 As such, 
upon excitation at 370 nm, the more intense TO emission for PFPTO relative 
to that for free TO/PFP should benefit from its covalently-linked donor-
acceptor architecture that ensures more efficient FRET. 
4.3.5. Recognition of dsDNA in Serum 
To demonstrate that PFPTO is able to recognize dsDNA in biological 
media, DNA titration experiments were conducted in 1×PBS buffer containing 
10 vol% serum. Serum is plasma without fibrinogen or other clotting factors, 
which contains proteins, glucose, mineral ions, hormones and other biological 
substances.129,130 In these experiments, [RU] is 2 μM and [DNA] varies from 0 




in serum upon addition of different amount of dsDNA and excitation at 370 
nm. In the absence of DNA, the nonspecific interaction between TO and the 
components in serum induces some background TO emission. However, 
addition of dsDNA into the polymer solution leads to continuous fluorescence 
increase in TO emission. The fluorescence response of PFPTO saturates at 
[DNA] = 7.2 nM. This DNA concentration is slightly lower than that obtained 
in pure PBS buffer (8.2 nM). In addition, the total intensity increment (ΔI) is 
~104 a.u., which is also slightly lower than that for PFPTO solution in the 
absence of serum (~130 a.u.). These discrepancies should stem from the 
partially-hampered contact between PFPTO and dsDNA in serum-containing 
solution. 
 


































      
Figure 4.8. PL spectra of PFPTO (a) in the presence of dsDNA with [DNA] 
ranging from 0 to 7.2 nM at intervals of 1.2 nM, and (b) in the absence of 
DNA, and in the presence of dsDNA or ssDNA at [DNA] = 7.2 nM. [RU] = 2 
μM in 1× PBS containing 10 vol% serum. (c) Photographs of fluorescence for 
PFPTO solutions at [RU] = 2 μM in the presence of ssDNA with [DNA] = 7.2 
nM, and in the presence of dsDNA with [DNA] ranging from 0 to 6.0 nM at 
intervals of 1.2 nM in 1× PBS containing 10 vol% serum under a hand-held 
UV lamp with λmax = 365 nm.  
Figure 4.8b compares the fluorescence response of PFPTO toward 
dsDNA against ssDNA in the serum-containing buffer at [DNA] = 7.2 nM, 
together with the PL spectrum of PFPTO in the absence of DNA. The 
presence of ssDNA in the PFPTO solution does not increase the TO emission 
owing to the screened contact between PFPTO and ssDNA by serum, and the 
TO emission intensity in the presence of dsDNA is substantially higher than 
that in the presence of ssDNA. As such, PFPTO is capable of distinguishing 
dsDNA from ssDNA in biological media. Figure 4.8c shows the fluorescent 
color of the polymer solutions in the absence of DNA, in the presence of 
ssDNA at [DNA] = 7.2 nM, and dsDNA at [DNA] ranging from 1.2 to 6.0 nM 
at intervals of 1.2 nM. In the absence of DNA, the fluorescent color of 
PFPTO solution is blue. The blue fluorescence retains in the presence of 
ssDNA, while it gradually changes to antique brass with increasing [dsDNA]. 
Consequently, naked-eye discrimination of dsDNA from ssDNA in a mixed 




the dsDNA concentration can be qualitatively estimated according to the 
fluorescent color change of the polymer solution. 
4.4. Conclusion 
Intercalating dye is harnessed to CPEs through a facile and effective 
postpolymerization procedure to construct a macromolecular fluorescent probe 
for multicolor dsDNA sensing. UV-vis absorption and PL spectra of PFPTO 
in water illustrate that the optical properties of the covalently-linked TO 
within PFPTO is similar to that of free TO, indicating that the rotation of the 
central methine in the TO side chain is not significantly affected by the 
attachment. This feature allows PFPTO to offer a dark fluorescence 
background of TO at 535 nm for light-up detection of dsDNA. The 
intercalation character of the TO units within PFPTO leads to a preferred 
fluorescence response toward dsDNA, which can be applied to effectively 
distinguish dsDNA from ssDNA. In addition, the light-harvesting property of 
the conjugated backbone of PFPTO substantially amplifies the intercalated 
TO signaling emission upon excitation of the polymer backbone, enabling 
naked-eye detection of dsDNA.  
Comparison of PFPTO with the free TO/PFP system not only 
demonstrates that PFPTO outperforms the TO/PFP system in dsDNA 
discriminability, but also highlights the importance of linked donor-acceptor 
architecture in efficient FRET. The most significant advantage of PFPTO is 
its applicability for naked-eye recognition of dsDNA in serum where 




harnessed CCP is appropriate for label-free dsDNA detection in mixed 
samples.  
In summary, we have demonstrated a new and practical concept to 
construct multicolor CPEs with a distinct fluorescence signature toward 
dsDNA through integrating a fluorescent bio-recognition element into CPEs as 
the side chain. Such design circumvents the expensive and time-consuming 
nucleic acid labeling process, providing new opportunities for real-time naked-
eye detection of dsDNA or DNA hybridization in mixed samples. Furthermore, 
intercalating dye harnessed CPEs are promising candidates for DNA 
microarray technology in light of their in-situ amplified signals upon 
excitation of the conjugated backbone.131 To achieve a signaling emission at 
different wavelengths, other intercalating dyes can be tethered to a proper CPE 
structure. However, the optoelectronic properties of the intercalating dye and 
the CPE should be simultaneously optimized for efficient FRET.77 The dye-
harnessed CPE design could also be generalized for the detection of other 







CONJUGATED POLYELECTROLYTE BLEND AS 
PERTURBABLE ENERGY TRANSFER ASSEMBLY FOR 
MULTICOLOR FLUORESCENT RESPONSES TOWARD 
PROTEINS 
5.1. Introduction 
Reliable technologies for efficient and convenient protein detection are of 
scientific importance and economic interest due to their vital implications in 
proteomics, medical diagnostics, and pathogen detection.67,111 The structural 
complexity and environmental sensitivity of proteins relative to other 
biomolecules necessitate extra severe considerations for the sensory design.68 
Challenges in protein sensing primarily lie on the creation of sensory materials 
not only featuring appropriate receptors for efficient binding with target 
proteins but also bearing perturbable functionalities for sensitive transduction 
of recognition events. In this regard, CPEs comprising π-conjugated 
fluorescent backbones with amenable water-soluble side chains well meet 
these criteria, providing a unique optical platform for protein sensing.131,132 In 
particular, their large absorption extinction coefficients and rapid 
intramolecular/intermolecular exciton migration make CPEs light-harvesting 
antennae in optical transduction, ultimately imparting amplified signals and 
improved sensitivity relative to traditional small fluorophores.6, 7, 60 
Protein detection based on fluorescent, colorimetric or FRET properties of 
CPEs has been reported. Fluorescence quenching of CPEs towards proteins 




protein discrimination according to the pattern of Stern-Volmer quenching 
constants;133,134 whereas, conformation-dependent absorption behaviors of 
cationic PT in association with strong aptamer/protein binding allowed for 
specific colorimetric recognition of human thrombin.54, 72 In addition, 
distance-dependent FRET between CPEs and dye-attached biomolecules led to 
both array-based 135 and specific protein assays.136,137 In comparison with 
fluorescence quenching and colorimetric protocols, FRET strategy has the 
advantage of dual-channel signal collection, consequently giving rise to 
reduced possibility of false-positive signals.63,138 However, since biomolecular 
labeling is laborious and complicated,139 the requirement of dye-attached 
biomolecules to participate in FRET sensing strongly constrains the assay 
applications. As a result, development of CPEs as label-free FRET probes for 
protein sensing is highly desirable.  
In this chapter, we demonstrate that CPE blend comprising energy 
donor-acceptor polymers can be utilized as sensitive FRET assembly for 
multicolor fluorescence responses toward proteins. In particular, such a 
FRET blend is also able to exhibit distinguishable fluorescence in the 
presence of three metalloproteins including ferritin (Fer), myoglobin (Myo) 
and CytC. Since previous CPE-based method to discriminate these 
metalloproteins was less successful due to their similar fluorescence 
quenching effect,4 our CPE blending concept should greatly advance CPE-






The same instruments as those in Chapter 2 are used for the experiments.  
5.2.2. Materials 
All proteins were purchased from Sigma-Aldrich Chemical Company and 
were used as received. Fetal Bovine Serum was purchased from HyClone. 
10×PBS buffer with pH = 7.4 (ultrapure grade) is a commercial product of 1st 
BASE Singapore. MilliQ water (18.2 MΩ) was used to prepare the buffer 
solutions from the 10×PBS stock buffer. 1×PBS contains NaCl (137 mM), 
KCl (2.7 mM), Na2HPO4 (10 mM), and KH2PO4 (1.8 mM). Fresh stock 
solutions for PFVP (1 mM), PFVBT (1 mM), and proteins (1 mM) were 
prepared before use.  
5.2.3. Synthesis 
5.2.3.1. 9,9-Bis(6'-bromohexyl)-2,7-divinylfluorene (2) 
2,7-Dibromo-9,9-bis(6-bromohexyl)-fluorene (1) (1.30 g, 2.0 mmol), 
tributylvinyltin (1.33 g, 4.2 mmol), PdCl2(PPh3)2 (56 mg, 0.09 mmol), 2,6-di-
tert-butylphenol (8 mg, 38 mmol), and toluene (20 mL) were mixed in a 50 
mL flask. The reaction mixture was stirred and heated at 100 °C for 24 h under 
N2. After cooling to the room temperature, the mixture was diluted with ether 
and treated with KF solution (~10%), which was followed by stirring for 12 h. 
The mixture was then filtrated to remove the insoluble solid, and the filtrate 
was dried over anhydrous Na2SO4. The solvent was removed under reduced 
pressure, and the residue was purified by silica gel chromatograph using 




crystals. 1H NMR (500 MHz, CDCl3, δ ppm): 7.62 (d, 2 H, J = 7.83 Hz), 7.40 
(d, 2 H, J = 7.85 Hz), 7.35 (s, 2 H), 6.80 (dd, 2 H, J = 10.86, 17.58), 5.81 (d, 2 
H, J = 17.58 Hz), 5.27 (2 H, d, J = 10.86), 3.27 (t, 4 H, J = 6.81, 6.81), 1.97 
(m, 4 H), 1.65 (q, 4 H), 1.19 (q, 4 H), 1.07 (q, 4 H), 0.63 (m, 4 H). 13C NMR 
(125 MHz, CDCl3, δ ppm): 151.38, 141.39, 137.71, 136.99, 125.81, 120.78, 
120.19, 113.58, 55.21, 40.65, 34.35, 33.03, 29.43, 28.13, 23.86. Element 
analysis calcd (%) for C29H36Br2: C 63.98 H 6.67. Found: C 64.18, H 6.63. 
MS (MALDI-TOF): m/z 544.51 [M]+. 
5.2.3.2. 9,9-Bis(6'-(N,N,N,-trimethylammonium)-hexyl)-2,7-divinylfluorene 
dibromide (3) 
Condensed trimethylamine (~3 mL) was added dropwise to a solution of 2 
(163 mg, 0.30 mmol) in THF (5 mL) at -78 °C. The mixture was allowed to 
warm to room temperature. The precipitate was redissolved by adding H2O (5 
mL). After the mixture was cooled to -78 °C, additional trimethylamine (~3 
mL) was added. The mixture was stirred at room temperature for 24 h. After 
removal of the solvent, acetone was added to precipitate 3 (188 mg, 95%) as 
white powders. 1H NMR (500 MHz, CD3OD, δ ppm): 7.94 (d, 2H, J = 7.83), 
7.76 (s, 2 H), 7.69 (d, 2 H, J = 9.14), 7.08 (dd, 2 H, J = 10.93, 17.63), 6.61 (d, 
2 H, J = 17.63), 5.51 (d, 2 H, J = 10.93), 3.46-3.40 (m, 4 H), 3.29 (s, 18 H), 
2.42-2.26 (m, 4 H), 1.93-1.73 (m, 4 H), 1.52-1.35 (m, 8 H), 0.92-0.78 (m, 4 H). 
13C NMR (125 MHz, CD3OD, δ ppm): 152.28, 142.27, 138.52, 138.27, 126.63, 
121.55, 120.89, 113.72, 67.67, 56.14, 53.52, 41.01, 29.96, 26.63, 24.47, 23.41. 






A Schlenk tube was charged with 1 (140 mg, 0.212 mmol), 1,4-
dibromobenzene (4) (50 mg, 0.212 mmol), Pd(OAc)2 (2 mg, 9 μmmol), and 
P(o-tolyl)3 (15 mg, 49 μmol) before it was sealed with a rubber septum. The 
Schlenk tube was degassed with three vacuum-argon cycles to remove air. 
Then, DMF (1 mL), H2O (0.5 mL), and triethylamine (1 mL) was added to the 
Schlenk tube and the mixture was frozen, evacuated, and thawed three times to 
further remove air. The polymerization was carried out at 100 °C under 
vigorous stir for 12 h. It was then filtered through 0.22 μm syringe driven filter 
and the filtrate was poured into acetone. The precipitate was collected and 
redissolved in methanol. Finally, the polymer was purified by dialysis against 
Mill-Q water using a 6.5 kDa molecular weight cutoff dialysis membrane for 5 
days. After freeze-drying, PFVP (116 mg, 81%) was obtained as green fibers. 
1H NMR (500 MHz, CD3OD, δ ppm): 8.45-7.07 (m, 14 H), 3.62 (br, 4 H), 




A Schlenk tube was charged with 3 (140 mg, 0.212 mmol), 5 (62 mg, 
0.212 mmol), Pd(OAc)2 (2 mg, 9 μmmol), and P(o-tolyl)3 (15 mg, 49 μmol) 
before it was sealed with a rubber septum. The Schlenk tube was degassed 
with three vacuum-argon cycles to remove air. Then, DMF (1 mL), H2O (0.5 




was frozen, evacuated, and thawed three times to further remove air. The 
polymerization was carried out at 100 °C under vigorous stir for 12 h. It was 
then filtered through 0.22 μm syringe driven filter and the filtrate was poured 
into acetone. The precipitate was collected and redissolved in methanol. 
Finally, the polymer was purified by dialysis against Mill-Q water using a 6.5 
kDa molecular weight cutoff dialysis membrane for 5 days. After freeze-
drying, PFVBT (138 mg, 82%) was obtained as red fibers. 1H NMR (500 
MHz, CD3OD, δ ppm): 8.75-7.05 (m, 12 H), 6.91 (br, ~0.25 H) 5.95 (br, ~0.25 
H), 5.35 (br, ~0.25 H), 3.25 (br, 4 H), 3.07 (br, 18 H), 2.25 (br, 4 H), 1.60 (br, 
4 H), 1.21 (br, 8 H), 0.80 (br, 4 H). 13C NMR (125 MHz, CD3OD, δ ppm): 
155.23, 153.23, 142.21, 138.58, 135.10, 130.53, 128.78, 127.45, 125.42, 
120.40, 67.69, 56.42, 53.62, 41.13, 30.12, 26.73, 24.88, 23.58. 
5.3. Results and Discussion 
5.3.1. Sensing Mechanism 
The working mechanism of the multicolor strategy mainly takes 
advantage of distance-dependent FRET between a pair of donor-acceptor 
cationic CPEs to induce discrepant FRET efficiency in the presence of 
different proteins. In a similar way, the polymer fluorescence is also 
affected by PCT between metalloprotein and the polymers. The sensing 
mechanism is proposed in Scheme 5.1.  
In the absence of proteins, the average distance of donor-acceptor 
CPEs in solution is too large to favor efficient FRET since there is no 
electrostatic attraction between them owing to their same charge sign. 




the donor polymer. In contrast, addition of protein into the solution of CPE 
blend results in the complex formation of the polymers and protein due to 
the electrostatic and hydrophobic interactions among them, and thus the 
distance between donor-acceptor CPEs should be shortened to an extent 
determined by the net charge and hydrophobicity of each protein. As such, 
FRET efficiency increases differently upon addition of different proteins, 
ultimately leading to protein-dependent changes in the donor/acceptor 
emissions. In addition to FRET, electron transfer between metalloproteins 
and CPEs could also contribute to the variation of donor/acceptor 
emissions through fluorescence quenching provided that they are in close 
proximity. The combination of these effects should consequently afford 
multicolor fluorescent responses of CPE blend toward proteins. 
 
Scheme 5.1. Schematic illustration of multicolor responses of the CPE 




5.3.2. Synthesis and Characterization 
Two CPEs, PFVP and PFVBT (Scheme 5.2), chosen as energy donor and 
acceptor, respectively, were synthesized by Heck condensation polymerization 
in water/DMF media. The reaction medium for Heck polymerization generally 
involves a basic organic solvent, such as diisopropylamine or triethylamine 
(TEA). Due to the high reaction temperature (100 °C) in Heck polymerization, 
monomers with alkyl bromides are likely to react with the basic organic 
solvent, leading to insoluble byproducts. Therefore, a one-pot polymerization 
strategy was conducted to directly synthesize PFVP and PFVBT starting from 
a quaternary ammonium monomer. 
The synthetic route toward PFVP and PFVBT is shown in Scheme 5.2. 
The neutral divinyl monomer, 9,9-bis(6'-bromohexyl)-2,7-divinylfluorene (2), 
was synthesized in 78% yield by heating the mixture of 2,7-dibromo-9,9-
bis(6-bromohexyl)-fluorene (1) and tributylvinyltin in toluene using 
PdCl2(PPh3)2/2,6-di-tert-butylphenol as catalyst at 100 °C for 24 h. The 
correct chemical structure of 2 was proven by NMR and mass spectra as well 
as elemental analysis. Quaternization of 2 with trimethylamine in THF/H2O 
afforded the cationic divinyl monomer, 9,9-bis(6'-(N,N,N,-
trimethylammonium)-hexyl)-2,7-divinylfluorene dibromide (3), in 95% yield. 
Finally, the water-soluble divinyl monomer 3 was copolymerized with 1,4-
dibromobenzene (4) and 4,7-dibromobenzothiadiazole (5) via a Pd(OAc)2/P(o-
tolyl)3 catalyzed Heck coupling reaction in the mixture of DMF/H2O/TEA (2 : 
1 : 2) at 100 °C to directly afford the water-soluble cationic polymer PFVP 
and PFVBT, respectively. Both polymers were purified by micro-filtration, 




molecular weight cutoff dialysis membrane for 5 days. The limit of water-
solubility for PFVP and PFVBT is ~3 mg/mL.  
 
Scheme 5.2. Synthesis of PFVP and PFVBT. Conditions and reagents: (i) 
Tributylvinyltin, PdCl2(PPh3)2/2,6-di-tert-butylphenol, toluene, 100 °C, 24 h; 
(ii) trimethylamine, THF/H2O, -78 °C, 24 h; (iii) Pd(OAc)2/P(o-tolyl)3, 
DMF/Water/TEA, 100 °C, 12 h. 
The chemical structures of PFVP and PFVBT were determined by 1H and 
13 C NMR spectra. Using PFVBT as an example, the configurations of the 
polymers are investigated. As shown Figure 5.1, the absence of resonance 
peak at ~6.5 ppm illustrates that PFVBT does not have cis vinyl protons.140 
The resonance peak of trans vinyl protons at ~7.4 ppm is present and mixed 
with those of aryl protons, giving rise to a broad peak with the maximum at 
7.78 ppm. The ratio of the integrated area of the multiple peaks ranging from 
8.17-7.05 ppm (corresponding to the aryl and vinyl protons) to that of the peak 




fluorene units) is nearly 3, which is consistent with the chemical structure of 
PFVBT. In addition, the weak peaks at 6.91, 5.95, and 5.35 ppm are ascribed 
to the resonance of vinyl protons of fluorenylvinylene end groups of PFVBT. 
Comparison of the integrated areas between the peak at 5.95 ppm and the peak 
at 2.25 ppm reveals that the number-average DP of PFVBT is ~15. These 
NMR data not only indicate the correct chemical structure of PFVBT, but also 
clarify that PFVBT has trans-CH=CH configuration, which is in accordance 
with the previous studies of Heck polymerization.141 The trans configuration 
of PFVBT is beneficial to biosensor application, because it facilitates 
backbone planarization and electron delocalization along the backbone, 
bringing in a red-shifted absorption and emission spectra as compared to its cis 
counterpart.142 
 
Figure 5.1. 1H NMR spectrum of PFVBT in CD3OD. Asterisk indicates the 
solvent peak. The spectrum is broken to eliminate the strong peak of water at 
4.87 ppm. 
5.3.3. Optical Properties 
The normalized UV-vis absorption and PL spectra of PFVP and PFVBT 




PFVP and PFVBT are 452 and 487 nm, 515 and 679 nm, respectively. Good 
overlap between the emission of PFVP and the absorption of PFVBT 
indicates the feasibility of FRET from PFVP to PFVBT when they are in 
close proximity. 
 
Figure 5.2. Normalized UV-vis absorption and PL spectra of PFVP and 
PFVBT in water. 
To optimize the donor/acceptor ratio for multicolor responses toward 
proteins, the PL spectra of PFVP in the presence of different amount of 
PFVBT are first examined in 25 mM PBS (pH = 7.4) upon excitation of 
PFVP at 430 nm. In these experiments, the polymer concentration based on 
RU is 6 μM for PFVP, and 0 to 3.6 μM for PFVBT. As shown in Figure 5.3, 
with the increased ratio of [PFVBT]/[PFVP], the emission band ranging from 
625 nm to 800 nm gradually increases at the expense of the emission at 487 
nm, resulting in solution fluorescent color variation from green to white. The 
emission intensity at 625 nm upon excitation of PFVP at 430 nm is 10-fold 
higher than that upon direct excitation of PFVBT at 515 nm, indicating the 
amplification of PFVBT emission provided by PFVP through FRET. The 































occurrence of FRET in the presence of the polymers alone should originate 
from weak hydrophobic interactions caused by their intrinsically hydrophobic 
aromatic backbones. To acquire a wide range fluorescent change for 
multicolor responses, the optimum concentration ratio of PFVBT to PFPV is 
thus chosen to be 0.4, where the fluorescent color of the blend solution 
remains green. 
 
Figure 5.3. PL spectra of PFVP/PFVBT mixtures in 25 mM PBS with the 
ratio ranging from 0 to 0.6. [PFVP] = 6 μM, excitation at 430 nm or 515 nm.  
5.3.4. Fluoresecence Responses toward Proteins 
The fluorescence responses of a blend solution of PFVP (6 μM) and 
PFVBT (2.4 μM) toward proteins is then studied in 25 mM PBS at pH = 7.4. 
The proteins include pepsin (Pep), Fer, ConA, BSA, thrombin (Thro), Myo, 
trypsin (Trp), and CytC, which have the isoelectric point (pI) values of ~2.9, 
4.4, 4.7, 4.8, 7.1, 7.2, 10.5, and 10.7, respectively. Fer, Myo and CytC are 
metaloproteins, while others are nonmetaloproteins. The PL spectra of the 
polymer blend in the absence and presence of each protein at the saturation 
point are shown in Figure 5.4. Addition of nonmetaloproteins into the blend 
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solution leads to the protein-dependent fluorescence intensity increase at 625 
nm and intensity decrease at 487 nm, indicating that the FRET from PFVP to 
PFVBT is enhanced due to the formation of multicomponent complexes 
between the polymers and the protein. In addition, the extent of the intensity 
increase of the acceptor emission at 625 nm generally follows the amount of 
net negative charges of the protein, which proves that electrostatic attraction 
between the polymers and the protein controls the donor-acceptor distance and 
in turn the FRET efficiency.  
        
Figure 5.4. PL spectra of PFVP/PFVBT blend in 25 mM PBS at pH = 7.4 in 
the absence and presence of proteins. [PFVP] = 6 μM and [PFVBT] = 2.4 μM. 
[Con A] = 1 μM, [BSA] = 0.7 μM, [Typ] = 0.9 μM, [CytC] = 0.8 μM, [Myo] = 
0.9 μM, [Pep] = 0.6 μM, [Thro] = 0.6 μM, [Fer] = 0.6 μM. Excitation at 430 
nm. 
Unlike nonmetaloproteins, the working mechanism for metaloproteins 
could involve electron transfer in addition to FRET, which functions at a 
considerably shorter distance as compared to that of FRET.143,144 Among these 
metaloproteins, only Fer has a large amount of net negative charges at pH = 
7.4. Thus, strong electrostatic attraction between Fer and the polymers exists 
to induce the formation of compact complexes, within which the distance 































between the polymers and the metal components of Fer is short enough to 
allow electron transfer and consequently lead to significant fluorescence 
quenching at both 487 and 625 nm. In contrast, for CytC and Myo, the weak 
protein/polymer interactions can only satisfy the distance requirement for 
FRET rather than electron transfer among them. As such, the blend solution 
shows intensity increase at 625 nm and intensity decrease at 487 nm in the 
presence of CytC or Myo. 
 
Figure 5.5. Changes in the emission intensities at 487 nm (ΔIG) and at 625 nm 
(ΔIO) of PFVP/PFVBT blend in the presence of proteins at saturation point, 
and the photographs of the corresponding fluorescent solutions under UV-
radiation at 365 nm. The left green-fluorescent cuvette corresponds to the 
blend solution in the absence of proteins. [PFVP] = 6 μM and [PFVBT] = 2.4 
μM. [Con A] = 1 μM, [BSA] = 0.7 μM, [Typ] = 0.9 μM, [CytC] = 0.8 μM, 
[Myo] = 0.9 μM, [Pep] = 0.6 μM, [Thro] = 0.6 μM, and [Fer] = 0.6 μM. 
Excitation at 430 nm. 
The changes in the emission intensities at 487 nm (ΔIG) and 625 nm (ΔIO) 




summarized in Figure 5.5, together with photographs of the corresponding 
fluorescent solutions. Except Fer, all other proteins induce fluorescence 
intensity decreases at 487 nm and intensity increases at 625 nm for the 
polymer blend, the extent of which differs from each other. Therefore, the 
green fluorescence of the polymer blend turns into pink, orange, red or brown 
in the presence of these proteins. On the contrary, efficient quenching of the 
polymer fluorescence by Fer results in dark color, which is different from 
other proteins. PFVP/PFVBT blend thus exhibits multicolor fluorescent 
signals towards proteins, allowing one to discriminate Fer from these selected 
proteins by naked-eye under UV radiation.  
5.3.5. Ferritin Dection in Serum  
To explore the potential utility of the CPE blend in real-world protein 
sensing, the fluorescence responses of PFVP (6 μM) and PFVBT (2.4 μM) 
toward proteins are examined in 25 mM PBS containing 10 vol% serum. The 
PL spectra of the polymer blend in the absence and presence of Pep, CytC or 
Fer at the saturation point are shown in Figure 5.6.  
The presence of serum in PBS induces a significant intensity increase at 
625 nm for the blend due to the complexation between the polymers and the 
biological substances in serum, leading to white fluorescent color of the 
solution. Except Pep and Fer, addition of other proteins slightly changes the 
PL spectrum of the blend owing to the shield effect of the biological 
substances in serum. However, since Pep and Fer have the largest amount of 
net negative charges among these proteins, they still can interact with the 




625 nm occurs for Pep, changing the solution fluorescent color into orange; 
while fluorescence quenching at both 487 and 625 nm is induced by Fer, 
leading to dark fluorescent color of the solution. Despite the similar effect of 
Pep and Fer on the fluorescence of the blend in serum containing solution to 
that in pure PBS, the protein concentrations required for saturation increase 
because of the interference of the biological substances in serum. Nevertheless, 
the fact that addition of Fer still can effectively quench the fluorescence of the 
CPE blend in serum media indicates the feasibility of Fer discrimination from 
the selected proteins in real samples. 
 
Figure 5.6. PL spectra of PFVP/PFVBT blend in 25 mM PBS containing 10 
vol% serum in the absence and presence of proteins. [PFVP] = 6 μM and 
[PFVBT] = 2.4 μM. [Con A] = 4.0 μM, [BSA] = 3.5 μM, [Typ] = 4.2 μM, 
[CytC] = 4.0 μM, [Myo] = 4.5 μM, [Pep] = 3.6 μM, [Thro] = 3.6 μM, [Fer] = 
3.2 μM. Excitation at 430 nm.  
5.4. Conclusion 
In conclusion, we have shown for the first time that CPE blend can 
constitute a sensitive FRET system to generate multicolor fluorescence 
responses toward proteins. With PFVP and PFVBT as a pair of energy donor-
acceptor, dark color is only observed for Fer among the selected proteins both 






























in pure PBS and serum containing media due to its strong fluorescence 
quenching effect, which highlights the potential application of CPE blend in 
visual detection of Fer. It is also suggested that CPE blend containing more 
than two polymers could form combinatorial FRET among them, which is 
likely to bring in a more colorful fluorescent pattern relative to that of Figure 
5.5 for visual protein sensing. As a consequence, our blending strategy 
provides new opportunities for label-free multicolor chemical and biological 






POLYELECTROLYTE AND OLIGOMER AS AN SMART 
ENERGY TRANSFER PAIR FOR DETECTION OF 
CONCANAVALIN A 
6.1. Introduction 
ConA, a lectin obtained from jack beans (Canavalia ensiformis), is often 
used as a model protein to study sugar–protein interaction because it is less 
toxic than other lectins such as ricin, Boulium toxin and Escherichia coli (E. 
Coli) toxin.145 Because of its specific binding to both glucose and mannose-
containing receptors, Con A plays a key role in cell adhesion and recognition 
of pathogens, such as viruses, bacteria, fungi, and protozoa.146 It is also one of 
the most useful biological substances in studying cell carbohydrates and 
characterization of glycoproteins.147 Individual carbohydrate–protein 
interaction is generally weak, which could be compensated by multiple 
cooperative interactions between the carbohydrate and proteins. One example 
is to attach many carbohydrate units to the polymer side chains and the 
resulting multivalent interactions between the carbohydrates and proteins have 
been demonstrated to be much stronger than the corresponding monovalent 
interaction.148,149 Although CPE-based detection of ConA has been reported 
previously, most of them relies on fluorescence quenching as sensing protocol, 
which do not allow for the naked-eye sensing.37,150-152  
In the previous chapters, we have developed CPEs with energy donor-




hypothesis is that FRET becomes more efficient upon polymer aggregation 
because of stronger electronic coupling and increased energy transfer 
dimensionality for interchain vs intrachain interactions.151 Polymer 
aggregation concurs with CPE/protein complexation to favor both intrachain 
and interchain FRET from the donor segments to the acceptor units, leading to 
fluorescent color changes.  
In Chapter 4, we have also developed CPE blending system to show 
multicolor responses towards proteins. However, as the sensing mechanism is 
based on nonspecific electrostatic and hydrophobic interactions between CPE 
blending system and proteins, the fluorescent signals are simply dependent on 
the nature of each protein (e.g. net charge, hydrophobicity, and components). 
As such, this blending probe does not have protein specificity. On the other 
hand, recognition groups were covalently attached to BT-containing polymers 
as the side chains in an attempt to bring specific polymer/protein binding into 
sensing operation.151 Unfortunately, the specific binding failed to significantly 
outperform nonspecific interference to dominate the fluorescence signatures. 
The above information reveals that single-component FRET systems 
generated from incorporation of low-energy units into CPEs cannot provide 
very efficient protein sensing, which intrinsically stems from the strong 
hydrophobic and charged nature of both CPEs and proteins.  
In this chapter, we show that a CPE and a neutral conjugated oligomer can 
serve as an intelligent bicomponent FRET probe for highly-selective label-free 
visual detection of ConA. Considering the high affinity between mannose and 
ConA,13 both PF-based energy-donating CPE (P1) and BT-based energy-




recognition groups (chemical structures shown in Scheme 6.1). As conjugated 
polymers fully substituted with mannose groups are hard to be dissolved in 
aqueous solution,156 half of the side chains of P1 is designed to have charges 
in order to maintain water solubility. By virtue of its short hydrophobic 
aromatic backbone and nonionic nature, 6 should have weak interactions with 
nonspecific proteins. As such, FRET between P1 and 6 is anticipated to 
selectively occur in the presence of ConA, leading to label-free naked-eye 
sensing of ConA.  
 






The same instruments as those in Chapter 2 are used for the experiments.  
6.2.2. Materials 
All proteins were purchased from Sigma-Aldrich Chemical Company and 
were used as received. Fresh stock solutions for P1 (1 mM based on RU), 6 (1 
mM) and proteins (0.1 mM) were prepared before use. Other chemicals and 
biological reagents were purchased from Sigma-Aldrich Chemical Company, 
and were used as received.  
6.2.3. Synthesis 
6.2.3.1. Synthesis of 2-Propynyl-2,3,4,6-tetra-O-acetyl-α-D-mannopyranose 
A solution of 1,2,3,4,6-Penta-O-acetyl-a-d-mannopyranose (1.5614 g, 4 
mmol) in 1,2-dichloroethane was treated with SnCl4 (0.46 mL, 4 mmol) for 20 
min. 2-Propynyl alcohol (0.3364 g, 6 mmol) was then added and the mixture 
was stirred at room temperature for 5 h. The reaction mixture was quenched 
with 5% aqueous NaHCO3 (20 mL). After extraction with chloroform, the 
combined organic layers were washed with water three times and dried over 
MgSO4. After solvent removal, the residue was purified with neutral Al2O3 
column chromatography using dichloromethane/hexane (1:1 v/v) as the eluent 
to afford 4 as white crystals (0.8921 g, 57.7%). 1H NMR (300 MHz, CDCl3, δ 
ppm): 5.26-5.31 (m, 3H), 5.02 (s, 1 H), 4.25-4.31 (m, 3 H), 4.01-4.12A (m, 2 
H), 2.46 (t, 1 H), 1.98-2.15 ppm (m, 12 H). 13C NMR (75 MHz, CDCl3, δ 
ppm): 170.57, 169.88, 169.78, 169.64, 96.23, 77.89, 75.54, 69.33, 68.97, 




TOF): m/z 386.3 [M+]. Elemental analysis: calcd (%) for C17H22O10 : C 52.85, 
H 5.74; found: C 52.85, H 5.29. 
 
6.2.3.2. Synthesis of 2-(9,9-Bis(2-(2-(2-bromoethoxy)ethoxy)ethyl)fluorenyl)-
4,4,5,5-tetramethyl-1,3,2-dioxaborolane (1) 
2-Bromo-9,9-bis(2-(2-(2-bromoethoxy)ethoxy)ethyl)fluorene (3.18 g, 5 
mmol), bis-(pinacolato)diborane (1.5 g, 6 mmol), KOAc (1.75 g, 17.5 mmol), 
and anhydrous dioxane (50 mL) were mixed together. After degassing, 
[Pd(dppf)Cl2] (0.125 g) was added. The reaction mixture was stirred at 90 °C 
overnight, and then cooled to room temperature. The organic solvent was 
distilled out, and the residual solid was dissolved in dichloromethane and 
washed with water. After drying with Na2SO4, the solvent was distilled out. 
The crude product was purified by silica gel chromatography (hexane/ethyl 
acetate = 5:1) to give 1 as white crystals (2.89 g, 85%). 1H NMR (500 MHz, 
CDCl3, δ ppm): 7.85-7.77 (m, 2 H), 7.73-7.64 (m, 2 H), 7.48-7.38 (m, 1 H), 
7.37-7.28 (m, 2 H), 3.65 (t, 4 H, J = 6.42 Hz), 3.42-3.30 (m, 8 H), 3.22-3.12 
(m, 4 H), 2.83-2.62 (m, 4 H), 2.50-2.30 (m, 4 H), 1.38 (s, 12 H). 13C NMR 
(125 MHz, CDCl3, δ ppm): 149.40, 147.87, 143.33, 140.19, 134.07, 129.12, 
127.83, 127.22, 123.13, 120.20, 119.08, 83.80, 71.03, 70.26, 69.83, 67.03, 
51.05, 39.53, 30.08, 24.91. MS (MALDI-TOF): m/z 682.15 [M+]. 
6.2.3.3. Synthesis of 4,7-Bis(9,9-bis(2-(2-(2-
bromoethoxy)ethoxy)ethyl)fluorenyl)benzothiadiazole (3) 
1 (3.14 g, 4.60 mmol), 4,7-dibromobenzothiadiazole (2) (0.64 g, 2.2 
mmol), Pd(PPh3)4 (53 mg, 0.046 mmol), and potassium carbonate (4.43 g, 




(12 mL) and toluene (30 mL) was added to the flask and the reaction vessel 
was degassed. The mixture was vigorously stirred at 90 °C for 2 days. After it 
was cooled to room temperature, dichloromethane was added to the reaction 
mixture. The organic portion was separated and washed with brine before 
drying over anhydrous Na2SO4. The solvent was evaporated off, and the solid 
residues were purified by column chromatography on silica gel using 
hexane/ethyl acetate (1:3) to afford 3 as grassy yellow solid (1.9 g, 70%). 1H 
NMR (500 MHz, CDCl3, δ ppm): 8.13-8.02 (m, 4 H), 7.91 (s, 2 H),7.87 (2 H, 
d, J = 8.52 Hz), 7.77 (d, 2 H, J = 6.50 Hz), 7.48 (d, 2 H, J = 7.90), 7.38 (p, 2 H, 
J = 7.21, 7.19 Hz), 3.64 (t, 8 H, J = 6.41), 3.42 (dd, 8 H, J = 3.60, 5.70 Hz), 
3.35 (t, 8 H, J = 6.41 Hz), 3.26 (dd, 8 H, J = 3.68, 5.50 Hz), 3.08-2.78 (m, 8 
H), 2.65-2.35 (m, 8 H). 13C NMR (125 MHz, CDCl3, δ ppm): 154.25, 149.41, 
149.34, 140.69, 140.06, 136.38, 133.31, 128.72, 127.99, 127.69, 127.45, 
124.01, 123.24, 120.14, 119.91, 71.06, 70.35, 69.91, 67.28, 51.45, 39.68, 
30.14. MS (MALDI-TOF): m/z 1244.15 [M+]. Elemental analysis: calcd for 
C56H64Br4N2O8S: C 54.03, H 5.18; found: C 54.12, H 5.21. 
6.2.3.4. Synthesis of 4,7-Bis(9,9-bis(2-(2-(2-
azidoethoxy)ethoxy)ethyl)fluorenyl)benzothiadiazole (4) 
3 (0.88 g, 0.71 mmol), NaN3 (0.23 g, 3.57 mmol), and DMF (4 mL) were 
placed in a 25 mL round bottom flask. The reaction mixture was stirred at 
room temperature for 24 h and filtered to remove NaN3 and NaBr. The filtrate 
was washed with water and extracted with CH2Cl2. The organic phase was 
separated and dried over Na2SO4. After removal of the solvent, the residue 
was purified by silica gel column chromatography using hexane/ethyl acetate 




(500 MHz, CDCl3, δ ppm): 8.15-8.04 (m, 4 H), 7.93 (s, 2 H),7.88 (2 H, d, J = 
8.52 Hz), 7.78 (d, 2 H, J = 6.50 Hz), 7.50 (d, 2 H, J = 7.90), 7.40 (p, 2 H, J = 
7.21, 7.19 Hz), 3.55 (t, 8 H, J = 6.41), 3.44 (dd, 8 H, J = 3.60, 5.70 Hz), 3.36 (t, 
8 H, J = 6.41 Hz), 3.27 (dd, 8 H, J = 3.68, 5.50 Hz), 3.09-2.80 (m, 8 H), 2.67-
2.37 (m, 8 H). 13C NMR (125 MHz, CDCl3, δ ppm): 154.28, 149.43, 149.35, 
140.71, 140.10, 136.41, 133.33, 128.74, 128.00, 127.71, 127.48, 124.03, 
123.26, 120.17, 119.94, 71.08, 70.37, 69.94, 67.31, 51.47, 50.40, 39.72. 
6.2.3.5. Synthesis of 5 
2-Propynyl-2,3,4,6-tetra-O-acetyl-α-D-mannopyranose (1.31 mg, 3.4 
mmol) and 4 (0.77 g, 0.7 mmol) were dissolved in THF (6 mL). An aqueous 
solution of sodium ascorbate (67 mg, 0.34 mmol) and copper (II) sulphate (27 
mg, 0.17 mmol) was then added. The mixture was vigorously stirred at room 
temperature for 24 h, and then it was washed with water and extracted with 
CH2Cl2. The organic phase was separated and dried over Na2SO4. After 
removal of the solvent, the residue was purified by silica gel column 
chromatography using hexane/ethyl acetate (2:1) as the eluent to afford 5 (1.5 
g, 82%) as grassy yellow solid. 1H NMR (500 MHz, CDCl3, δ ppm): 8.10-8.02 
(m, 4 H), 7.90 (s, 2 H), 7.87 (d, 2 H, J = 7.88 Hz), 7.78 (d, 2 H, J = 6.80 Hz), 
7.61 (s, 4 H), 7.49 (d, 2 H, J = 7.05 Hz), 7.43-7.33 (m, 4 H), 5.30 (m, 8 H), 
5.21 (m, 4 H), 4.94 (s, 4 H), 4.78 (d, 4 H, J = 13.05 Hz), 4.62 (d, 4 H, J = 
13.80 Hz), 4.42 (t, 8 H, J = 5.10 Hz), 4.28 (dd, 4 H, J = 4.92, 12.08 Hz), 4.15-
4.00 (m, 8 H), 3.70 (t, 8 H, J = 5.18 Hz), 3.35 (m, 8 H), 3.21 (m, 8 H), 3.0-
2.82 (m, 8 H), 2.58-2.38 (m, 8 H), 2.13 (s, 12 H), 2.10 (s, 12 H), 2.02 (s, 12 H), 
1.96 (s, 12 H). 13C NMR (125 MHz, CDCl3, δ ppm): 170.65, 169.98, 169.82, 




128.00, 127.73, 127.56, 125.51, 124.08, 123.32, 120.21, 119.99, 96.82, 70.49, 
69.85, 69.48, 69.27, 69.07, 68.69, 67.30, 66.11, 62.37, 60.87, 51.55, 50.20, 
39.73, 20.86, 20.77, 20.68, 20.65. MS (MALDI-TOF): m/z 2638.70 [M+].  
6.2.3.6. Synthesis of 6 
After 5 (500 mg, 0.19 mmol) was dissolved in the mixture of methanol (6 
mL) and dichloromethane (10 mL), CH3ONa in methanol solution (3 mL, 1 M) 
was added. The mixture was stirred at room temperature for 6 h. After rotary 
evaporation of the solvents, the residue was dissolved in water. Finally, the 
compound was purified by dialysis against Mill-Q water using a 1.5 kDa 
molecular weight cutoff dialysis membrane for 2 days. After freeze-drying, 6 
(324 mg, 87%) was obtained as grassy yellow solid. 1H NMR (500 MHz, 
CD3OD, δ ppm): 8.22 (s, 2 H), 8.15-8.06 (m, 4 H), 8.01 (d, 2 H, J = 7.94 Hz), 
7.96 (s, 4 H), 7.90 (d, 2 H, J = 7.98 Hz), 7.62 (d, 2 H, J = 6.53 Hz), 7.40 (p, 4 
H, J = 7.10, 7.05 Hz), 4.70 (s, 4 H), 4.71-4.67 (m, 4 H), 4.62 (d, 4 H, J = 12.18 
Hz), 4.51 (d, 4 H, J = 5.69 Hz), 4.38 (t, 8 H, J = 5.31 Hz), 3.75-3.60 (m, 12 H), 
3.56 (br, 4 H), 3.50-3.33 (m, 12 H), 3.30-3.25 (m, 8 H), 3.17-3.09 (m, 8 H), 
2.92-2.70 (m, 8 H), 2.48-2.30 (m, 8 H). 
6.2.3.7. Synthesis of 9,9-Bis(2-(2-(2-azidoethoxy)ethoxy)ethyl)-2,7-
dibromofluorene (8) 
7 (1.52 g, 2.13 mmol), NaN3 (0.69 g, 10.7 mmol), and DMF (10 mL) were 
placed in a 25 mL round bottom flask. The reaction mixture was stirred at 
room temperature for 24 h and filtered to remove NaN3 and NaBr. The filtrate 
was washed with water and extracted with CH2Cl2. The organic phase was 




was purified by silica gel column chromatography using 
hexane/dichloromethane (1:4) as the eluent to afford 8 (1.26 g, 93%) as white 
crystals. 1H NMR (500 MHz, CDCl3, δ ppm): 7.54 (s, 2 H), 7.51 (d, 2 H, J = 
8.09 Hz), 7.47 (d, 2 H, J = 8.25 Hz), 3.54 (t, 4 H, J = 5.10 Hz), 3.38 (m, 4 H), 
3.32 (t, 4 H, J = 5.07 Hz), 3.19 (m, 4 H), 2.80 (t, 4 H, J = 7.22 Hz), 2.34 (t, 4 
H, J = 7.23 Hz). 13C NMR (125 MHz, CDCl3, δ ppm): 151.00, 138.50, 130.67, 
126.76, 121.61, 121.24, 70.48, 70.07, 69.97, 66.89, 51.98, 50.60, 39.48.  
6.2.3.8. Synthesis of 9 
2-Propynyl-2,3,4,6-tetra-O-acetyl-α-D-mannopyranose (1.31 mg, 3.4 
mmol) and 8 (890 mg, 1.4 mmol) were dissolved in THF (6 mL). An aqueous 
solution of sodium ascorbate (67 mg, 0.34 mmol) and copper (II) sulphate (27 
mg, 0.17 mmol) was then added. The mixture was vigorously stirred at room 
temperature for 24 h, and then it was washed with water and extracted with 
CH2Cl2. The organic phase was separated and dried over Na2SO4. After 
removal of the solvent, the residue was purified by silica gel column 
chromatography using hexane/ethyl acetate (2:1) as the eluent to afford 9 
(87%, 1.72 g) as colorless viscous liquid. 1H NMR (500 MHz, CDCl3, δ ppm): 
7.64 (s, 2 H), 7.55 (s, 2 H), 7.52 (d, 2 H, J = 8.08 Hz), 7.47 (d, 2 H, J =9.59 
Hz), 5.30 (m, 4 H), 5.22 (s, 2 H), 4.94 (s, 2 H), 4.80 (d, 2 H, J=12.26 Hz,), 
4.65 (d, 2 H, J=12.20 Hz,), 4.47 (t, 4 H, J=5.11 Hz), 4.28 (dd, 2 H, J =4.98, 
12.24 Hz), 4.10 (m, 4 H), 3.73 (t, 4 H, J = 5.17 Hz), 3.32 (dd, 4 H, J = 3.69, 
5.44 Hz), 3.14 (dd, 4 H, J = 3.90, 5.24 Hz), 2.80 (t, 4 H, J = 7.05 Hz), 2.33 (t, 
4 H, J = 7.05 Hz), 2.13 (s, 6 H), 2.10 (s, 6 H), 2.02 (s, 6 H), 1.96 (s, 6 H). 13C 
NMR (125 MHz, CDCl3, δ ppm): 170.63, 169.95, 169.79, 169.66, 151.01, 




69.45, 69.33, 69.04, 68.68, 66.90, 66.09, 62.36, 60.88, 52.10, 50.22, 39.44, 
20.83, 20.75, 20.66, 20.63. MS (MALDI-TOF): m/z 1410.33 [M+]. 
6.2.3.9. Synthesis of 2-(9,9-Bis(2-(2-(2-methoxyethoxy)ethoxy)ethyl)-7-
(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)fluorenyl)-4,4,5,5-tetramethyl-
1,3,2-dioxaborolane (10) 
7 (3.55 g, 5 mmol), bis-(pinacolato)diborane (3.0 g, 12 mmol), KOAc (3.5 
g, 35 mmol), and anhydrous dioxane (50 mL) were mixed together. After 
degassing, [Pd(dppf)Cl2] (0.25 g) was added. The reaction mixture was stirred 
at 90 °C overnight, and then cooled to room temperature. The organic solvent 
was distilled out, and the residual solid was dissolved in dichloromethane and 
washed with water. After drying with Na2SO4, the solvent was distilled out. 
The crude product was purified by silica gel chromatography using 
hexane/ethyl acetate (5:1) as the eluent to give 10 as white crystals (3.25 g, 
80%). 1H NMR (300 MHz, CDCl3, δ): 7.89-7.70 (m, 4 H), 7.76-7.65 (m, 2 H), 
3.66 (t, 4 H, J = 6.4 Hz), 3.38 (dd, 8 H, J = 5.8 Hz, J = 12.3 Hz), 3.16 (t, 4 H, J 
= 4.7), 2.69 (t, 4 H, J = 7.5 Hz), 2.44 (t, 4 H, J = 7.5 Hz), 1.39 (s, 24 H). 13C 
NMR (75 MHz, CDCl3 δ): 148.51, 143.11, 134.05, 129.21, 119.52, 83.84, 
71.08, 70.31, 69.89, 67.00, 51.04, 39.47, 30.11, 24.93. MS (MALDI-TOF): 
m/z 808.25 [M+]. Elemental analysis: calcd for C37H54B2Br2O8: C 54.98, H 
6.73; found: C 55.17, H 6.69.  
6.2.3.10. Synthesis of P0 
A Schlenk tube was charged with 9 (352 mg, 0.25 mmol), 10 (202 mg, 
0.25 mmol), Pd(PPh3)4 (2.5 mg) and potassium carbonate (415 mg, 3.0 mmol) 




with three vacuum-argon cycles to remove air. Water (1.5 mL) and toluene 
(2.5 mL) were then added to the Schlenk tube and the mixture was frozen, 
evacuated, and thawed three times to further remove air. The polymerization 
was then carried out at 90 °C under vigorous stir for 12 h. The mixture was 
washed with water and extracted with CHCl3. After the organic phase was 
separated, dried over MgSO4 and concentrated, the residue was poured into 
methanol. The precipitate was filtered and then dried under vacuum for 24 h to 
afford P0 (345 mg, 75%) as white fibers. 1H NMR (500 MHz, CDCl3, δ ppm): 
8.14-7.31 (m, 14 H), 5.29 (m, 4 H), 5.22 (br, 4 H), 4.95 (s, 2 H), 4.79 (m, 2 H), 
4.64 (m, 2 H), 4.46 (m, 4 H), 4.27 (m, 2 H), 4.07 (m, 4 H), 3.74 (m, 4 H), 3.64 
(m, 4 H), 3.55-3.09 (m, 20 H), 3.02-2.76 (m, 8 H), 2.70-2.37 (m, 8 H), 2.15-
1.91 (m, 24 H). 13C NMR (125 MHz, CDCl3, δ ppm): 170.67, 169.98, 169.83, 
169.69, 150.12, 143.24, 143.18, 140.46, 139.55, 134.54, 134.02, 130.69, 
130.54, 126.79, 124.04, 121.60, 121.53, 121.28, 120.45, 96.81, 83.91, 71.08, 
70.50, 70.36, 70.04, 69.96, 69.49, 69.73, 69.08, 68.69, 67.31, 67.15, 66.13, 
62.39, 60.90, 60.85, 50.57, 50.15, 39.93, 39.72, 30.31, 24.99, 20.86, 20.77, 
20.68, 20.66.  
6.2.3.11. Synthesis of P1 
After P0 (40.0 mg) was dissolved in the mixture of methanol (6 mL) and 
dichloromethane (10 mL), CH3ONa in methanol solution (3 mL, 1 M) was 
added. The mixture was stirred at room temperature for 6 h for deacetylation. 
After rotary evaporation of the solvents, the residue was washed with water 
and ethanol, and dissolved in THF (8 mL). Condensed trimethylamine (~2 mL) 
was added dropwise to the solution at -78 °C. The mixture was allowed to 




methanol (10 mL). After the mixture was cooled to 78 °C, additional 
trimethylamine (~2 mL) was added, and the mixture was stirred at room 
temperature for 24 h. After removal of the solvent, acetone was added. The 
precipitate was filtered and then dried under vacuum for 24 h to afford P1 (36 
mg, 82%) as white powders. 1H NMR (500 MHz, CD3OD, δ ppm): 8.36-7.48 
(m, 14 H), 4.72 (s, 4 H), 4.68-4.58 (m, 4 H), 4.53-4.45 (m, 4 H), 4.43-4.32 (br, 
8 H), 3.78-3.62 (br, 12 H), 3.56 (br, 4 H), 3.41 (br, 12 H), 3.23-3.09 (m, 8 H), 
3.03 (m, ~18 H), 2.80 (br, 8 H), 2.48-2.40 (br, 8 H). 
6.3. Results and Discussion  
6.3.1. Synthesis and Characterization 
A post-functionalization strategy based on click chemistry was adopted to 
synthesize mannose-substituted conjugated oligomer 6 as shown in Scheme 
6.2. In the first step, 2-(9,9-bis(2-(2-(2-bromoethoxy)ethoxy)ethyl)fluorenyl)-
4,4,5,5-tetramethyl-1,3,2-dioxaborolane (1) was synthesized in 85% yield by 
heating a mixture of 2-bromo-9,9-bis(2-(2-(2-
bromoethoxy)ethoxy)ethyl)fluorene and bis(pinacolao)diborane with KOAc in 
dioxane at 85 °C for 12 h. This is followed by the palladium-mediated Suzuki 
cross-coupling reaction between 1 and 4,7-dibromobenzothiadiazole (2), 
which led to 4,7-bis(9,9-bis(2-(2-(2-
bromoethoxy)ethoxy)ethyl)fluorenyl)benzothiadiazole (3) in 70% yield. 
Subsequently, treatment of 3 with sodium azide in DMF at room temperature 
gave 4,7-bis(9,9-bis(2-(2-(2-
azidoethoxy)ethoxy)ethyl)fluorenyl)benzothiadiazole (4) in 92% yield. In the 




tetra-O-acetyl-α-D-mannopyranose was carried out in THF/water at room 
temperature to afford acetylated precursor 5 in 82% yield.  
 
Scheme 6.2. Synthesis of mannose-substituted conjugated oligomer (6). 
Reagents and conditions: i) Pd(PPh3)4, K2CO3, H2O/toluene, 90 °C, 48 h; ii) 
NaN3, DMF, room temperature, 24 h; iii) 2-propynyl-2,3,4,6-tetra-O-acetyl-α-
D-mannopyranose, sodium ascorbate, CuSO4, THF/H2O, room temperature, 24 
h; iv) CH3ONa, CH3OH/CH2Cl2, room temperature, 6 h. 
The 1H NMR spectrum of 5 is shown in Figure 5.1. A single resonance 
peak of the proton next to the nitrogen atom of the triazole group (-NCH=C-, 
peak a) appears at 7.61 ppm, while the triple resonance peak of the methylene 
protons next to the triazole group (-OCH2-CH2-C-, peak c) is downshifted to 
4.42 ppm as compared to that of 4 at 3.44 ppm. Moreover, the single 
resonance peaks of the acetyl protons are also found at 2.13, 2.10, 2.02 and 
1.96 ppm, respectively. These characteristic peaks are indicative of successful 
attachment of acetylated mannose to the fluorene units. After deacetylation of 




molecular weight cutoff dialysis membrane, the mannose-substituted 
conjugated oligomer 6 was obtained in 87% yield. The disappearance of the 
resonance peaks of the acetyl protons in the 1H NMR spectrum of 6 indicates 
complete deacetylation. The oligomer 6 has a high water-solubility of ~28 
mg/mL, which benefits from its high density of mannose groups and short 
aromatic backbone.  
 
Figure 6.1. 1H NMR spectrum of 5 in CDCl3. Asterisk and hex indicate the 
peaks of CDCl3 and acetone, respectively. 
The CPE (P1) with both cationic and mannose side chains was 
synthesized according to Scheme 6.3. Treatment of 2,7-dibromo-9,9-bis(2-(2-
(2-bromoethoxy)ethoxy)ethyl)fluorene (7) with sodium azide in DMF at room 
temperature gave 9,9-bis(2-(2-(2-azidoethoxy)ethoxy)ethyl)-2,7-
dibromofluorene (8) in 92% yield. The CuI-catalyzed click reaction between 8 
and 2-propynyl-2,3,4,6-tetra-O-acetyl-α-D-mannopyranose led to monomer 9 






dioxaborolane (10) was synthesized in 80% yield by heating a mixture of 7 
and bis(pinacolao)diborane with KOAc in dioxane at 85 °C for 12 h. The 
correct structures of monomers 9 and 10 were confirmed by NMR and mass 
spectrometry.  
 
Scheme 6.3. Synthesis of mannose-substituted CPE (P1): i) NaN3, DMF, 
room temperature, 24 h; ii) 2-propynyl-2,3,4,6-tetra-O-acetyl-α-D-
mannopyranose, sodium ascorbate, CuSO4, THF/H2O, room temperature, 24 h; 
iii) bis-(pinacolato)diborane, KOAc, [Pd(dppf)Cl2], anhydrous dioxane, 90 °C; 
iv) Pd(PPh3)4, K2CO3, H2O/toluene, 90 °C, 12 h; v) CH3ONa, CH3OH/CH2Cl2, 




The standard Suzuki cross-coupling mediated polymerization between 9 
and 10 provided the neutral precursor P0 in 78% yield. The number-average 
molecular weight and polydispersity of P0 are 13000 and 2.8, respectively, 
determined by GPC using THF as the solvent and polystyrene as the standard. 
The 1H NMR spectrum of P0 is shown in Figure 6.2. The resonance peaks of 
the methylene protons next to the triazole group (-NCH2O-, peak a) and the 
second-next to the triazole group (-OCH2-CH2-C-, peak b) are located at 5.29 
and 3.74 ppm, respectively. The integrated area of each peak is equal to that of 
the peak at 3.64 ppm corresponding to -OCH2-CH2Br (peak c). In addition, the 
characteristic peaks of the acetylated mannose groups are also found. The 
NMR spectrum indicates the correct chemical structure of P0.  
After deacetylation of P0 under Zemplém conditions using sodium 
methylate in methanol/dichloromethane, followed by quaternization with 
trimethylamine in THF/methanol, P1 was obtained in 82%. The disappearance 
of the acetyl proton peaks in the 1H NMR spectrum of P1 indicates the 
complete deacetylation, while the theoretically-consistent integrated area for 
the new resonance peak at 3.03 ppm corresponding to -CH2CH2N(CH3)3 
reveals that the degree of quaternization is  higher than 95%. This polymer 
was purified by precipitation and dialysis against Mill-Q water using a 6.5 
kDa molecular weight cutoff dialysis membrane for 5 days. The water-
solubility of P1 is low (~3 mg/mL), which should be caused by its long 





Figure 6.2. 1H NMR spectrum of P0 in CDCl3. Asterisk and hex indicate the 
peaks of CDCl3 and acetone, respectively.  
6.3.2. Optical Properties 
The UV-Vis absorption and PL spectra of P1 and 6 are depicted in Figure 
6.3. The concentration for P1 based on RU and 6 based on molecule is 1 µM. 
The absorption and emission maxima of P1 are located at 382 and 422 nm, 
respectively, which are similar to those of water-soluble PF.157 The absorption 
spectrum of 6 has two bands centered at 312 and 413 nm, corresponding to 
fluorene and BT, resepectively, while its emission maximum is at 570 nm. The 
quantum yields of P1 and 6 in water are 0.55 and 0.32, respectively, measured 
using quinine sulfate in 0.1 M H2SO4 (quantum yield = 0.55) as the standard. 
The emission spectrum of P1 well overlaps the absorption spectrum of 6 in the 
range of 380 to 500 nm, which should favor energy transfer between them for 
protein sensing.77,158 
To optimize the donor/acceptor molar ratio for sensitive optical response 
toward proteins, the PL spectra of P1 in the presence of different amount of 6 




MnCl2 (0.1 mM) upon excitation at 370 nm. In these experiments, the donor 
concentration [P1 RU] is fixed at 1 μM with the acceptor concentration ([6]) 
varying from 0 to 0.6 μM at intervals of 0.1 μM.  
        
Figure 6.3. UV-vis absorption (dashed line) and PL (solid line) spectra of P1 
and 6 in water. [P1 RU] = 1 µM and [6] = 1 µM.  
 
Figure 6.4. PL spectra of 6/P1 blend in 15 mM PBS (pH = 7.4) containing 
CaCl2 (0.1 mM) and MnCl2 (0.1 mM) with the molar ratio ranging from 0 to 
0.6 µM at intervals of 0.1 µM. [[P1 RU] =1 µM. Excitation at 370 nm. 
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As shown in Figure 6.4, with the increased ratio of [6]/[P1], the blue 
emission centered at 422 nm gradually deceases, while the yellow emission 
band ranging from 518 nm to 650 nm slightly increases. The spectral change is 
indicative of weak FRET between P1 and 6 due to nonspecific interactions. 
The yellow emission of 6 saturates at [6]/[P1] = 0.5, where the fluorescent 
color of the blend solution remains blue; whereas, the blue emission of P1 
continues to decrease with further addition of 6, making the fluorescent color 
white. As such, the optimum molar ratio of 6 to P1 for protein sensing is 
chosen to be 0.5, which represents the highest allowable concentration of 6 to 
ensure blue background fluorescence.  
6.3.3. Protein Sensing 
The fluorescence responses of 6/P1 blend at the optimal ratio ([P1 RU] =1 
µM and [6] = 0.5 µM) toward proteins were investigated in PBS buffer (15 
mM, pH = 7.2) containing CaCl2 (0.1 mM) and MnCl2 (0.1 mM). The tested 
proteins include ConA, bovine serum albumin (BSA), thrombin (Thro), 
myoglobin (Myo), trypsin (Trp), cytochrome c (CytC), and lysozyme (Lys) 
which have the isoelectric point (pI) values of 4.7, 4.8, 7.1, 7.2, 10.5, 10.7, and 
11, respectively. As shown in Figure 6.5, the yellow emission of 6 at 550 nm 
progressively increases at the expense of the blue emission of P1 at 422 nm 
with increased ConA addition. The saturation occurs at [ConA] = 150 nM, 
where the yellow emission intensity is higher than that of the blue emission. 
The PL spectra of 6/P1 blend in the presence of nonspecific proteins with the 




Different from ConA, nonspecific proteins almost do not enhance the 
acceptor emission, but change the donor emission differently. To 
quantitatively analyze the nonspecific interactions between protein and 6/P1 
blend, the intensity ratio of the yellow emission at 550 nm to the blue emission 
at 422 nm (I550/I422) for each protein is summarized in Figure 6.6b. It is 
obvious that only ConA shows I550/I422 > 1, reflecting a high signal-to-noise 
ratio of 6/P1 blend for ConA sensing. The photographs of the corresponding 
fluorescent solutions of 6/P1 blend in the presence of different proteins are 
shown in Figure 6.6c. Due to the large I550/I422, the fluorescent color of 6/P1 
blend turns into yellow in the presence of ConA, while it remains blue for 
other proteins. As a result, naked-eye discrimination of ConA from 
nonspecific proteins is feasible, which has not been realized so far for CPE 
based assays.  
 
Figure 6.5. PL spectra of 6/P1 blend in PBS (15 mM, pH = 7.2) containing 
CaCl2 (0.1 mM) and MnCl2 (0.1 mM) in the absence and presence of Con A 
with the concentration ranging from 0 to 150 nM at intervals of 30 nM. [P1 
RU]] = 1 µM and [6] = 0.5 µM. Excitation at 370 nm.  





















The distinguishable fluorescence signature of P1/6 blend toward ConA 
from nonspecific proteins proves the protein-selective energy transfer from P1 
to 6, which originates from specific binding between the mannose groups of 6 
and ConA. The proposed mechanism is briefly illustrated in Scheme 6.4. 
ConA predominantly exists as a tetramer of four identical subunits in neutral 
or alkaline solutions, which has four binding sites for α-mannose units to bind 
in the presence of Ca2+ and Mn2+ ions.159 In view of the high density of α-
mannose substitutes for both P1 and 6, ConA can act as an effective linker to 
bring P1 and 6 into close proximity to form multicomponent complexes within 
which intermolecular contact increases to favor FRET (Scheme 6.4).  
In addition, as ConA (pI = 4.7) has net negative charges at pH = 7.2, 
electrostatic attraction between oppositely-charged P1 and ConA exists to 
tighten the complexes, which further promotes electronic coupling within the 
FRET pair. As a result of these combinational effects, efficient FRET from P1 
to 6 yields yellow fluorescence in the presence of Con A. Moreover, the 
presence of Ca2+ and Mn2+ ions in the detection medium provides a stronger 
yellow fluorescence response toward ConA for 6/P1 blend as compared to that 
in the absence of these metal ions (Figures 5.7). This observation implies that 
the formation of ConA tetramer is beneficial to FRET between P1 and 6 to 






                      
Figure 6.6. (a) PL spectra of 6/P1 blend in PBS (15 mM, pH = 7.2) containing 
CaCl2 (0.1 mM) and MnCl2 (0.1 mM) in the absence and presence of proteins. 
[P1 RU] = 1 µM, [6] = 0.5 µM and [protein] = 150 nM. Excitation at 370 nm. 
(b) The intensity ratio of the yellow emission of 6 at 550 nm to the blue 
emission of P1 at 422 nm (I550/I422) as a function of proteins. The data are 
extracted from Figure 6.6a. (c) The photographs of the corresponding 
fluorescent solutions in Figure 6.6a under UV radiation at 365 nm. 
 

















































Scheme 6.4. Schematic illustration of protein-selective energy transfer from 
P1 to 6. 
On the contrary, nonspecific proteins do not have strong interactions with 
6 which cannot substantially shorten the distance between P1 and 6 to favor 
FRET (Scheme 6.4). However, the long aromatic backbone and positively-
charged side chains of P1 make the hydrophobic and electrostatic interactions 
between P1 and nonspecific proteins inevitable. Thereby, the emission of P1 
changes in the presence of nonspecific proteins depending on the charge and 
hydrophobicity of proteins. It is important to note that although Myo (pI = 7.2) 
has net neutral changes at pH = 7.2, it induces the most obvious intensity 
decrease in polymer emission among nonspecific proteins (Figure 6.6a). This 
is due to the metal center of Myo, which can quench the polymer fluorescence 
through charge transfer.34 Nevertheless, the solution fluorescence of 6/P1 





Figure 6.7. PL spectra of the solution of 6/P1 blend and Con A in PBS (15 
mM, pH = 7.2) in the absence (red line) and presence (black line) of CaCl2 
(0.1 mM) and MnCl2 (0.1 mM). [P1 RU] = 1 µM, [6] = 0.5 µM and [ConA] = 
150 nM. Excitation at 370 nm. 
6.3.4. Protein Quantification  
To demonstrate the quantification capability of 6/P1 blend, changes in the 
PL spectra in Figure 6.5 are correlated with ConA concentration. It results 
from subtraction of I550/I422 in the absence of protein from that in the presence 
of ConA. The calibration parameter φ is defined as the increment in I550/I422 
after addition of ConA. Figure 6.8a shows φ as a function of [ConA] together 
with its trendline. The validity of ConA quantification using 6/P1 blend is 
verified by the good overlap between the linear trendline and the original data 
in the range of 0 to 150 nM. The deviation from the trendline above 150 nM is 
caused by the saturation of the yellow emission at 550 nm.  
To determine the limit of detection (LOD) for 6/P1 blend in Con A 
quantification, PL experiments were conducted with a diluted blend solution 
with [P1 RU] = 0.1 μM and [6] = 0.05 μM in PBS (15 mM, pH = 7.2) 
containing CaCl2 (0.1 mM) and MnCl2 (0.1 mM). As shown in Figure 6.8b, a 



















progressive emission intensity increase is observed at 550 nm with ConA 
addition. Further decreasing the concentration of 6/P1 blend does not cause 
the fluorescent enhancement at 550 nm in the presence of 1.5 nM ConA. 
These data reveal that detectable complexation-induced FRET from P1 to 6 
occurs only when the analyte concentration is above 1.5 nM. As a result, the 
LOD for 6/P1 blend in ConA quantification is ~1.5 nM, which is significantly 
lower than that reported for mannose-substituted PF-based polymers 
quantifying ConA via fluorescent quenching.152,156 
 
Figure 6.8. (a)  as a function of [Con A] and its trendline. The data are based 
on the average of three independent experiments. (b) PL spectra of 6/P1 blend 
in PBS (15 mM, pH = 7.2) containing CaCl2 (0.1 mM) and MnCl2 (0.1 mM) in 
the absence and presence of Con A with the concentration ranging from 0 to 
4.5 nM at intervals of 1.5 nM. [[P1 RU]] = 0.1 µM and [6] = 0.05 µM. 
Excitation at 370 nm.  
6.4. Conclusion 
In conclusion, we synthesized a mannose-substituted cationic CPE (P1) 
and a mannose-substituted neutral conjugated oligomer (6) with blue and 
yellow emission, respectively. The spectral overlap between the polymer 
emission and the oligomer absorption enables us to blend them at an optimal 

































molar ratio to create a sensitive bicomponent FRET probe. By virtue of the 
neutral and highly water-soluble nature of 6 and specific mannose/ConA 
binding, the distance between P1 and 6 is substantially shortened in the 
presence of ConA instead of nonspecific proteins. Thus, 6/P1 blend exhibits 
efficient protein-selective FRET, allowing for label-free naked-eye sensing of 
ConA in a high-contrast and convenient manner. Moreover, this FRET probe 
can be implemented to quantify ConA, providing a lower LOD (~1.5 nM) as 
compared to those for PF-based fluorescence quenching probes. The findings 
shown in this work clearly highlight that incorporation of a neutral water-
soluble conjugate oligomer as the energy acceptor in sensing operation and 
signal transduction minimizes the interference of CPE/protein nonspecific 
interactions, consequently offering a new strategy for highly-selective protein 
sensing. This study provides fundamental guidelines and new opportunities for 






POSS AS UNIMOLECULAR NANOPARTICULATE 
ENERGY DONOR FOR FLUORESCENCE 
AMPLIFICATION IN CELL 
7.1. Introduction  
Fluorescence technologies are of vital significance in biological imaging 
owing to their easy operation, spatiotemporal resolution, and powerful 
interrogation of single components and events both in vitro and in vivo.162-164 
Intense fluorescent signals at low stain concentration with minimal laser 
power are always desirable for imaging, as these conditions minimize 
photodamage and dye toxicity to biological systems.165,166 However, most 
fluorophores suffer from low PL quantum yields in complex biological 
environment, signal amplification thus emerges as a major task in the 
advancement of fluorescence technologies.167,168 FRET, a long-range non-
radiative migration of energy between two nearby fluorophores, provides a 
convenient yet effective approach to enhance fluorescence.32 The extent of 
signal amplification is determined by FRET efficiency, which relies heavily 
on the optical properties of donor materials and the careful selection of donor-
acceptor pairs.158  
To amplify signals in live cells, the whole cell-permeability of donor 
molecules is desirable, which requires nanoscale size for the donors. In 
addition, three-dimensionality is another preferred character of donor 




nanoparticles are good candidates for FRET in biological systems. 
Semiconductor quantum dots (QDs) have been intensively explored as light-
harvesting antennae for intracellular biosensing and bioimaging.171 However, 
surface modification of QDs endows them with thick dielectric shells, which 
not only hamper their energy or electron transfer to optical partners,172,173 but 
also preclude them from entering cellular nuclei.174 These drawbacks lead to 
poor signal transduction and limited intracellular signal amplification.  
 
Scheme 7.1. Chemical structure of OFP. 
On the other hand, POSS, comprising a silicon-oxygen core surrounded 
by functional groups on the periphery, are novel building blocks to construct 
hybrid single-molecular nanoparticles.174 With good cytocompatibility and 
high chemical and thermal stability, POSS derivatives have been developed as 
high-performance nanocomposites for medical, aerospace, mechanical and 
optoelectronic applications.175,176 As a result of their bulky steric hindrance, 




fluorescent nanomaterials with tunable dimensions that possess higher PL 
quantum yields as compared to their linear counterparts.177-179 However, the 
current available POSS-based fluorescent materials are not water-soluble, and 
thus less suitable for biological applications. On account of these potential 
advantages of POSS over QDs, water-soluble POSS-based fluorescent 
molecules should constitute a new generation of energy donors for FRET in 
biological environment.  
In this chapter, we demonstrate a bottom-up strategy to construct water-
soluble fluorescent single-molecular nanoparticles based on POSS and 
cationic oligofluorene for fluorescence amplification in cellular imaging. 
Cationic oligofluorene substituted POSS (OFP, Scheme 7.1) is first 
synthesized and characterized to serve as the energy donor. Ethidium bromide 
(EB), an intercalating dye, is chosen as the energy acceptor, which exhibits 
fluorescence turn-on response toward dsDNA. FRET from OFP to EB is 
investigated both in buffer solution and in cells.  
7.2. Experiment 
7.2.1. Instruments 
In addition to the instruments used in in Chapter 2, a JEOL JEM-2010 
transmission electron microscope with an accelerating voltage of 200 kV was 
conducted to obtain high-resolution transmission electron microscopy (HR-
TEM) images. 
7.2.2. Materials 
Fetal bovine serum (FBS) was purchased from Gibco (Lige Technologies, 




ATG TGG GTG CT-3′, 5′-AGC ACC CAC ATA GTC AAG AT-3′) were 
purchased from Research Biolabs, Singapore. 3-(4,5-Dimethylthiazol-2-yl)-
2,5-diphenyl tetrazolium bromide (MTT) and penicillin-streptomycin solution 
were purchased from Sigma-Aldrich. Dulbecco’s modified essential medium 
(DMEM) was a commercial product of National University Medical Institutes 
(Singapore). Fresh stock solution of OFP (1 mM) was prepared before use.  
7.2.3. Cell cultures 
MCF-7 breast cancer cells and NIH 3T3 fibroblast were cultured in 
DMEM containing 10% FBS and 1% penicillin streptomycin at 37 °C in a 
humidified environment containing 5% CO2. Before experiment, the cells 
were pre-cultured until confluence was reached. 
7.2.4. Confocal Imaging 
MCF-7 cells were cultured in chamber (LAB-TEK, Chambered 
Coverglass System) at 37 °C for qualitative study. After 80% confluence, the 
medium was removed and the adherent cells were washed twice with 1×PBS 
buffer. OFP solution (1 μM, 0.8 mL) or OFP solution (1 μM, 0.8 mL) and EB 
solution (2 μM, 0.8 mL) were then added to the chamber. After incubation for 
2 h, cells were washed three times with 1×PBS buffer and then fixed by 75% 
ethanol for 20 minutes and further washed twice with 1×PBS buffer. The cell 
monolayer was washed twice with 1×PBS buffer and imaged by CLSM, Zeiss 




7.2.5. Cytotoxicity Test 
MTT assays were performed to assess the metabolic activity of NIH 3T3 
fibroblast. NIH 3T3 cells were seeded in 96-well plates (Costar, IL, USA) at 
an intensity of 2× 104 cells/mL. After 48 h incubation, the medium was 
replaced by OFP solution at the concentration of 0.01, 0.02 or 0.1 mg/mL, and 
the cells were then incubated for 8 and 24 h, respectively. After the designated 
time intervals, the wells were washed twice with 1×PBS buffer and freshly 
prepared MTT (100 μL, 0.5 mg/mL) solution in culture medium was added 
into each well. The MTT medium solution was carefully removed after 3 h 
incubation in the incubator. Isopropanol (100 μL) was then added into each 
well and gently shaken for 10 minutes at room temperature to dissolve all the 
precipitate formed. The absorbance of MTT at 570 nm was monitored by the 
microplate reader (Genios Tecan). Cell viability was expressed by the ratio of 
the absorbance of the cells incubated with OFP solution to that of the cells 
incubated with culture medium only. 
7.2.6. Synthesis  
7.2.6.1. 2-[9,9'-Bis(6''-bromohexyl)fluorenyl]-4,4,5,5-
tetramethyldioxaborolane (2) 
2-Bromo-9,9'-bis(6''-bromohexyl)fluorene (4.54 g, 7.95 mmol), bis(pi 
nacolatodiboron) (3.02 g, 11.93 mmol), and potassium acetate (2.94 g, 29.82 
mmol) were placed in a 100-mL round bottom flask. Anhydrous dioxane (80 
mL) and [Pd(dppf)Cl2] (0.20 g,0.24 mmol) were added to the flask and the 
reaction vessel was degassed. The mixture was stirred at 85 ºC for 12 h under 




removed by rotary evaporation. The residue was extracted with 
dichloromethane, and the organic phase was washed with water and brine, and 
dried over magnesium sulfate. The solvent was removed and the residue was 
purified by silica gel column chromatography (dichloromethane/hexane=1:2) 
to afford 2 (2.88 g, 59 %) as white crystals. 1H NMR (500 MHz,CDCl3, δ 
ppm): 7.84-7.71 (m, 4 H),7.35-7. 33 (m, 3H), 3.28–3.26 (t, J = 7.2 Hz, 4 H), 
2.03–1.96 (m, 4 H), 1.67–1.58 (q, 4H), 1.40 (s, 12 H),1.18–1.16 (q, 4 H), 
1.05–1. 03 (m, 4 H), 0.63–0.55 ppm (m, 4 H). 13C NMR (125 MHz,CDCl3, δ 
ppm): 151.12, 149.74, 144.32, 141.1, 134.12, 128.86, 127.81, 127.13, 123.21, 
120.43, 119.32, 83.92, 55.17, 40.39, 34.24, 32.81, 29.23, 27.9,5 25.22, 23.68 
ppm. MS (MALDI-TOF): m/z (%): 618.90 [M+]. 
7.2.6.2. 2-(7-Bromo-9,9'-bis(6''-bromohexyl)fluorenyl)-9,9'-bis(6''-
bromohexyl)fluorene (3) 
2,6-Dibromo-9,9'-bis(6''-bromohexyl)fluorene (2.84 g, 4.60 mmol), 2 (4.5 
g, 6.9 mmol), Pd(PPh3)4 (53 mg, 0.046 mmol), potassium carbonate (4.43, 
32.0 mmol) were placed in a 100 mL round bottom flask. A mixture of water 
(12 mL) and toluene (30 mL) was added to the flask and the reaction vessel 
was degassed. The mixture was vigorously stirred at 90 °C for 2 days. After it 
was cooled to room temperature, dichloromethane was added to the reaction 
mixture. The organic portion was separated and washed with brine before 
drying over anhydrous MgSO4. After the solvent was evaporated off, the solid 
residue was purified by column chromatography on silica gel using 
dichloromethane/hexane (1 : 5) as eluent to afford 3 (3.6 g, 0.68 %) as grassy 
liquid. 1H NMR (500 MHz, CD3Cl, δ ppm): 7.79 (d, 1 H J = 7.87 Hz), 7.77-




H), 7.41-7.29 (m, 3 H), 3.28 (q, 8 H, J = 6.95 Hz), 2.25-1.83 (m, 8 H), 1.80-
1.55 (m, 8 H), 1.34-1.03 (m, 16 H), 0.88-0.5.88 (m, 8 H). 13C NMR (125 MHz, 
CD3Cl, δ ppm): 152.87, 151.20, 150.79, 150.60, 141.02, 140.73, 140.58, 
140.21 139.85, 139.28, 130.20, 127.23, 127.01, 126.47, 126.24, 126.15, 
122.88, 121.22, 121.11, 120.15, 120.06, 118.87, 55.46, 40.23, 33.94, 32.62, 
30.07, 29.05, 27.76. MS (MALDI-TOF): m/z 1063.87 [M]+. 
7.2.6.3. 2-(7-Bromo-9,9'-bis(6''-N,N,N-trimethylammonium)hexyl fluorenyl)-
9,9'-bis(6''-N,N,N-trimethylammonium)hexyl fluorene tetra bromide (4) 
Condensed trimethylamine (~5 mL) was added dropwise to a solution of 3 
(1 g, 0.94 mmol) in THF (10 mL) at -78 °C. The mixture was allowed to warm 
to room temperature. The precipitate was redissolved by the addition of water 
(10 mL). After the mixture was cooled to -78 °C, additional trimethylamine 
(~3 mL) was added. The mixture was stirred at room temperature for 24 h. 
After removal of the solvent, acetone was added to precipitate 4 (1.2 mg, 98%) 
as white powders. 1H NMR (500 MHz, CD3OD, δ ppm): 7.90 (dd, 2 H, J = 
4.64, 7.88 Hz), 7.83-7.78 (m, 3 H), 7.77-7.72 (m, 3 H), 7.66 (s, 1 H), 7.55 (d, 1 
H, J = 9.68 Hz), 7.48 (d, 1 H, J = 7.74 Hz), 7.38 (q, 2 H, J = 7.08, 7.02 Hz), 
3.32-3.21 (m, 8 H), 3.09 (s, 36 H), 2.33-2.03 (m, 8 H), 1.77-1.49 (m, 8 H), 
1.35-1.03 (m 16 H), 0.83-0.49 (8 H). 13C NMR (125 MHz, CD3OD, δ ppm): 
154.59, 152.66, 152.35, 142.39, 141.70, 131.60, 128.38, 127.54, 124.28, 
122.68, 121.70, 67.84, 57.02, 53.78, 41.30, 30.42, 27.01, 24.95, 23.82.  
7.2.6.4. Synthesis of OFP 
Octavinyl POSS (5) (11.4 mg, 0.018 mmol), 4 (187 mg, 0.144 mmol), 




placed in a 25 mL round bottom flask. A mixture of DMF (1 mL), and 
triethylamine (0.5 mL) was added to the flask and the reaction vessel was 
degassed. The mixture was vigorously stirred at 100 °C for 36 h. It was then 
filtered and the filtrate was poured into acetone. After the precipitate was 
collected and washed with acetone, it was redissolved in water. The solution 
was filtered through a 0.22 μm syringe driven filter to give limpid solution. 
Finally, the product was purified by dialysis against Mill-Q water using a 3.5 
kDa molecular weight cutoff dialysis membrane for 5 days. After freeze-
drying, OFP (74 mg, 45%) was obtained as light yellow powders. 1H NMR 
(500 MHz, CD3OD, δ ppm): 7.91-7.86 (m, 2 H), 7.86-7.77 (m, 6 H), 7.77-7.73 
(m, 2 H), 7.72-7.67 (m, 1 H), 7.52-7.46 (m, 2 H), 7.42-7.33 (m, 2 H), 3.32-
3.18 (m, 8 H), 3.08 (s, 32), 2.4-2.05 (m, 8 H), 1.72-1.51 (m, 8 H), 1.38-1.09 
(m, 16 H), 0.86-0.60 (m, 8 H). 13C NMR (125 MHz, CD3OD, δ ppm): 153.04, 
152.87, 152.62, 152.03, 142.49, 142.21, 141.88, 138.44, 129.94, 128.42, 
127.46, 124.24, 122.32, 121.41, 121.05, 67.88, 56.61, 53.72, 41.36, 30.45, 
26.98, 24.98, 23.83.  
7.3. Results and Discussion  
7.3.1. Synthesis and Characterization  
The synthetic route toward OFP is depicted in Scheme 7.2. 2-[9,9'-Bis(6''-
bromohexyl)fluorenyl]-4,4,5,5-tetramethyldioxaborolane (2) was synthesized 
in 59% yield by heating a mixture of 2-bromo-9,9'-bis(6''-
bromohexyl)fluorene and bis(pinacolao)diborane with KOAc in dioxane at 
85 °C for 12 h. The palladium-mediated Suzuki cross-coupling reaction 





Quaternization of 3 with trimethylamine in THF/H2O afforded 2-(7-bromo-
9,9'-bis(6''-N,N,N-trimethylammonium)hexylfluorenyl)-9,9'-bis(6''-N,N,N-
trimethylammonium)hexylfluorene tetra bromide (4) in 98% yield. Finally, the 
water-soluble arm 4 was reacted with octavinyl POSS (5) via a Pd(OAc)2/P(o-
tolyl)3 catalyzed Heck coupling reaction in the mixture of DMF/TEA (2 : 1) at 
100 °C to afford the cationic OFP. The product was purified by micro-
filtration, precipitation, and finally dialysis against Mill-Q water using a 3.5 
kDa molecular weight cutoff dialysis membrane for 5 days.  
 
Scheme 7.2. Synthetic route to OFP. Reagents and conditions: (i) 
bis(pinacolato)diborane, [Pd(dppf)Cl2], KOAc, dioxane, 85 °C, 12 h; (ii) 2,7-
dibromo-9,9-bis(6-bromohexyl)fluorene, Pd(PPh3)4, Na2CO3, toluene/H2O, 90 
°C, 48 h; (iii) THF/H2O, NMe3, 24 h; (iv) Pd(OAc)2/P(o-tolyl)3, DMF/TEA, 




The chemical structure of OFP was determined by 1H and 13C NMR 
spectra. The single peak at 7.66 ppm in the 1H NMR spectrum of 4 assigned to 
the proton at 1-position of fluorene near bromide group is up-shifted to 7.50 
ppm in the 1H NMR spectrum of OFP. This is caused by the elimination of 
electron-withdrawing bromide group, indicating the successful attachment of 
the arm to POSS. Moreover, a new peak at 7.67 ppm assigned to the vinyl 
protons appears in the 1H NMR spectrum of OFP. Comparison of the 
integrated area between the peak at 7.67 ppm and that at 2.25 ppm (the alkyl 
protons next to the 9-position of fluorene units) reveals that nearly all the vinyl 
bonds of 5 are substituted by cationic oligofluorene owing to the high 
reactivity of Heck coupling reaction.181 
 
Figure 7.1. High resolution TEM image of OFP. 
The cationic OFP is well dissolved in methanol, dimethyl sulphoxide 
(DMSO) and water. The water-solubility of OFP is ~30 mg/mL at 24 ºC, 
which stems from the high-charge density on its spherical periphery. The 
morphology and size of OFP are studied by high-resolution transmission 




an average diameter of 3.6 ± 0.3 nm are observed, which is consistent with the 
single-molecular size of OFP as calculated from molecular simulation. 
Furthermore, the elemental composition of these nanoparticles is probed by in-
situ energy dispersive X-ray (EDX) analysis, which is consistent with the 
chemical structure of OFP.  
7.3.2. Optical Properties  
The optical properties of OFP in water are studied and compared with the 
arm 4. As shown in Figure 7.2, the absorption and emission maxima of OFP 
are 390 and 433 nm, respectively. Both are red-shifted by ~52 nm as 
compared to those of 4 as a result of the extended conjugation length through 
vinyl-silane link. A good overlap between the emission spectrum of OFP and 
the absorption spectrum of EB is thus achieved, which should favor FRET 
between them.  
 
Figure 7.2. Normalized UV-vis absorption spectra of the arm 4, OFP and EB 
(dashed line), and PL spectra of 4 and OFP (solid line) in water. 
The PL quantum yields of OFP and 4 in water are ~0.85 and 0.75, 
respectively, measured using quinine sulfate in 0.1 M H2SO4 (quantum yield = 
































0.55) as the standard. Moreover, the quantum yields of OFP and 4 in 150 mM 
PBS (pH = 7.4) are 0.80 and 0.28, respectively. The slightly decreased 
quantum yield of OFP at elevated ionic strength is ascribed to its nonlinear 
shape-persistent nano-architecture that prevents the fluorescent arms from 
close packing to form low-energy defects such as excimers and ground-state 
aggregates.94  
Noteworthy is that the quantum yields of most water-soluble cationic 
polyfluorene derivatives are less than ~0.60 in water, which are often 
significantly decreased at high ionic strength to less than 0.20 in buffer.182,130 
The strong fluorescence of OFP at high ionic strength makes it a perfect 
energy donor for optical amplification in cells.  
7.3.3. FRET in Solution 
The capability of OFP as an energy donor to amplify the signal of 
intercalating dye in buffer through FRET is evaluated first. FRET experiments 
were conducted in 25 nM PBS at [EB] = 2 μM and [ssDNA] or [dsDNA] = 20 
nM. In the absence of OFP, the PL intensities of EB/dsDNA and EB/ssDNA 
upon direct excitation of EB at 475 nm are ~16 and 10 a. u. at 610 nm, 
respectively. With the addition of OFP, the solution fluorescent signals are 
collected at 610 nm upon excitation of at OFP 390 nm. As shown in Figure 
7.3a, the OFP sensitized EB emission intensity increases significantly for 
EB/dsDNA when [OFP] is increased from 0 to 2 μM, which is followed by 
saturation. There is almost no change in EB emission intensity for the 







Figure 7.3. (a) PL intensity of EB at 610 nm as a function of [OFP] for 
EB/ssDNA/OFP and EB/dsDNA/OFP mixtures upon excitation at 390 nm. (b) 
PL spectra of EB/ssDNA and EB/dsDNA in the absence and presence of 2 μM 
OFP. (c) Photographs of the fluorescent solutions of EB/ssDNA and 
EB/dsDNA in the absence and presence of 2 μM OFP under 365 nm UV 
radiation. [ssDNA or dsDNA] = 20 nM and [EB] = 2 μM. 













































The PL spectra for both solutions at the saturation point are depicted in 
Figure 7.3b. For EB/dsDNA/OFP, two emission bands centered at 443 and 
610 nm are observed corresponding to the fluorescence of OFP and EB, 
respectively. The PL intensity for OFP sensitized EB/dsDNA emission at 610 
nm is 52-fold higher than that of EB/dsDNA upon direct excitation of EB at 
475 nm, indicating the signal amplification provided by OFP. On the other 
hand, only the emission band of OFP is present for EB/ssDNA/OFP. As a 
result of the discrepancies in signal amplification and spectral profiles, naked-
eye discrimination of dsDNA from ssDNA in the presence of OFP becomes 
feasible. As illustrated in Figure 7.3c, the fluorescence of EB/ssDNA or 
EB/dsDNA solution is very weak in the absence of OFP, while strong blue 
and pink fluorescent colors are observed for EB/ssDNA/OFP and 
EB/dsDNA/OFP solutions, respectively. 
7.3.4. Cell Imaging 
To demonstrate the signal amplification in cells, the cell permeability of 
OFP is first studied with breast cancer cells (MCF-7) as an example. After 
incubating MCF-7 cells with OFP solution (1 μM) for 2 h, the cells were fixed 
for fluorescent imaging studies. The excitation wavelength was fixed at 405 
nm, and the fluorescent signals were collected in the ranges of 430 to 470 nm 
and above 650 nm, respectively. It should be noted that the parameters of 
confocal laser scanning microscopy (CLSM) were optimized to have no 





Figure 7.4. CLSM of MCF-cells stained with OFP: (a) transmission image, (b) 
fluorescence image collected from 430 to 470 nm, and (c) fluorescence image 
collected above 650 nm. Excitation at 405 nm.  
The CLSM images are shown in Figure 7.4. Upon excitation at 405 nm, 
intensive blue fluorescence is observed upon collecting the signal from 430 to 
470 nm (Figure 7.4b), while no fluorescence is obtained above 650 nm (Figure 
7.4c). Such wavelength-dependent images are consistent with the PL spectrum 
of OFP in Figure 7.2, where the PL intensity approaches zero above 600 nm. 
More importantly, OFP is effectively internalized by MCF-7 cells and 
distributed in the entire cell. The permeability of OFP into the nuclei benefits 
from its small particle size (3.6 nm) which is within the effective 
transportation diameter of the nuclear pore complex (~9 nm).27 Thus, OFP 
traverses the nuclear pore complex by passive diffusion rather than a signal-
mediated process.184 The whole-cell permeability of OFP enables to amplify 
the fluorescent signal both in the cytoplasm and in the nucleus.  
FRET from OFP to EB in MCF-7 cell is then investigated. After 
incubation MCF-7 cells with EB solution (2 μM) for 1 h and then OFP 
solution (1 μM) for 1 h, the cells were fixed for fluorescent imaging studies. 
As shown in Figure 7.5a, when EB is excited at 488 nm, nearly dark image is 




although nuclei contain a lot of the genetic substances (such as DNA and RNA) 
that tend to increase the fluorescence of EB upon intercalation,185 the 
fluorescence of intercalated EB is too weak to afford a clear image under the 
operation conditions.186  
 
Figure 7.5. CLSM fluorescence images of MCF-cells co-stained by OFP and 
EB: (a) upon excitation at 488 nm and collection of fluorescence above 650 
nm; (b) upon excitation at 405 nm and collection of fluorescence above 650 
nm; (c) upon excitation at 405 nm and collection of fluorescence from 430 to 
470 nm; (d) overlapped image of b and c.  
In contrast, upon excitation of OFP at 405 nm and collection of the signal 
above 650 nm, red fluorescence is observed and mainly focused in the nuclei 
(Figure 7.5b). It should be noted that dark cellular image is observed for the 
cells stained by 2 μM EB alone upon excitation at 405 nm and collection of 
the signal above 650 nm under the same CLSM settings. Considering that 




excitation at 405 nm, this nucleus-highlighted cellular image should originate 
from the amplified EB emission sensitized by OFP through FRET.  
Moreover, upon excitation of OFP at 405 nm and collection the signal 
from 430 to 470 nm, blue fluorescence is observed for the whole cells 
resulting from OFP emission (Figure 7.5c). By overlapping the images of 
Figures 6.5b and 6.5c, the cytoplasm and the nucleus are indicated by blue and 
pink colors, respectively. These phenomena coincide well with the FRET in 
solution (Figure 7.3c), suggesting that efficient FRET occurs in cells. With the 
signal amplification provided by OFP via FRET, cellular image using dyes 
with weak fluorescence but long-wavelength emission is thus feasible. 
 
Figure 7.6. In-vitro viability of NIH 3T3 cells treated with OFP solutions at 
the concentration of 0.01 (blue), 0.02 (green) or 0.1 mg/mL (orange) for 8 and 
24 h. The percentage cell viability of treated cells is calculated relative to that 
of untreated cells with a viability arbitrarily defined as 100%. 
7.3.5. Cytotoxicity 
The cytotoxicity of OFP is tested for mouse embryonic fibroblast cells 
(NIH 3T3) using methylthiazolyldiphenyl-tetrazolium (MTT) cell-viability 
























or 0.1 mg/mL OFP for 8 or 24 h are summarized in Figure 7.6. Within the 
tested period, the cell viabilities are close to 100%, which indicates that OFP 
has low cytotoxicity and thus is a potential candidate for long-term clinical 
applications. 
7.4. Conclusion  
In conclusion, we demonstrate a bottom-up strategy to take advantage of 
POSS and conjugated oligoelectrolyte as building blocks to synthesize water-
soluble hybrid fluorescent unimolecular nanoparticles with a diameter of ~3.6 
nm. This fluorescent nanomaterial (OFP) possesses shape-persistent three-
dimensionality, high PL quantum yield in buffer, and excellent 
cytocompatibility. Of particular significance is that OFP can enter cellular 
nuclei due to its small diameter, which is rarely observed for other fluorescent 
nanomaterials, such as semiconductor QDs and gold nanoparticles.  
These desirable properties endue OFP with outstanding light-harvesting 
properties for efficient FRET in harsh biological environment. As a result, the 
fluorescence of intercalated EB is substantially amplified by 52-fold upon 
excitation of OFP in buffer as compared to upon excitation of EB itself, 
allowing naked-eye discrimination of dsDNA from ssDNA. Additionally, the 
strong signal amplification provided by OFP in cells and the whole-cell 
permeability of OFP make it feasible to clearly visualize the entire cellular 
structure with weakly-emissive commecial dyes (e.g. EB and TO).  
This study provides new opportunities to improve the performance of 
fluorescence technologies for biological imaging through a FRET approach 




applications, the high quantum yields and good signal amplification capability 
of POSS-based molecules can bring in high-quality biological images even 
with a small amount of indicator dyes, consequently avoiding the side effect of 





CONCLUSIONS AND RECOMMENDATIONS 
8.1. Conclusions 
We have designed and synthesized a series of new CPEs with the PF 
framework and applied them to constitute FRET probes for label-free visual 
biosensing. Firstly, a cationic PF derivative with 20 mol% BT content was 
synthesized to have an energy transfer backbone (Chapter 3). The high charge 
density and cationic oligo(ethylene oxide) side chains endue the polymer with 
good water solubility, leading to low inherent acceptor emission background 
prior to addition of analytes. The presence of negatively-charged heparin in 
the polymer solution induces polymer aggregation, giving rise to enhanced 
FRET from the fluorene segments to the BT units. With increasing heparin 
concentrations, the orange BT emission intensity progressively increases at the 
expense of the blue fluorene emission, allowing for visual quantification of 
heparin concentration. In contrast, addition of hyaluronic acid, an analog of 
heparin, results in an insignificant enhancement in BT emission. The different 
responses not only allow one to distinguish heparin from hyaluronic acid by 
naked eye, but also highlight the importance of electrostatic attraction in 
energy transfer process. However, since FRET is mainly determined by the 
electrostatic interactions between the CPE and the analyte, this single-
component CPE-based FRET probe has a moderate selectivity and can only be 
used for the detection of purified samples.  
Secondly, to increase the detection selectivity of the single-component 




capability as the energy acceptor to construct CPEs with energy transfer 
architecture (Chapter 4). To demonstrate this concept, an intercalating dye 
(TO) harnessed CPE is synthesized for dsDNA detection. This polymer design 
not only takes advantage of the high affinity between TO and dsDNA to 
realize dsDNA recognition in biological media, but also brings into play the 
light-harvesting feature of CPs to in-situ amplify the signal output of TO. The 
TO-harnessed CPE differentiates dsDNA from ssDNA more efficiently upon 
excitation of the conjugated backbone relative to that upon direct excitation of 
TO, as a result of efficient FRET from the polymer backbone to the 
intercalated TO. More importantly, the TO-harness CPE emits blue 
fluorescence in the presence of ssDNA, while its fluorescence gradually turns 
from blue to dark yellow with increased concentrations of dsDNA. This 
recognition capability remains in serum-containing solution where interfering 
biomolecules exist. These data indicate that the single-component CPE-based 
probe using fluorescent biorecognition element as the energy acceptor has a 
high sensing selectivity and thus holds great promise in the practical detection 
of mixed samples.  
Thirdly, in addition to DNA and heparin, proteins are chosen as the target 
species in order to demonstrate the feasibility of visual detection of more 
complicated biomolecules. Considering the stronger nonspecific interactions 
of CPEs with proteins as compared to that with other biomolecules, CPE-
based bicomponent FRET systems instead of single-component systems are 
applied. We have shown that CPE blend can constitute a sensitive probe to 
generate multicolor fluorescence responses toward proteins (Chapter 5). This 




induce discrepant FRET efficiency in the presence of proteins with different 
net charges, hydrophobicity and component. In particular, dark color is only 
observed for Fer among the selected eight proteins due to its strong 
fluorescence quenching effect. Accordingly, this CPE-based bicomponent 
FRET probe has a certain kind of selectivity toward Fer and may have 
potential application in label-free visual detection of Fer. However, this 
strategy cannot be generalized for the on purpose design of specific protein 
sensors because it is purely based on nonspecific-interaction-controlled energy 
and electron transfers.  
Fourthly, to provide a general method for label-free visual detection of 
protein with improved specificity, a CPE and a neutral water-soluble 
conjugate oligomer instead of two CPEs are utilized to constitute a 
bicomponent FRET probe (Chapter 6). Attachment of mannose units as the 
recognition groups to both the energy-donating CPE and the energy-accepting 
oligomer endows this FRET probe with high affinity toward ConA. Due to the 
selective occurrence of FRET in the presence of ConA, the fluorescence of 
this blend is dominated by yellow emission in the presence of ConA, while it 
remains blue in the presence of other nonspecific proteins. In addition to high 
selectivity, this FRET probe provides a lower LOD (~1.5 nM) for ConA 
quantification as compared to those for PF-based fluorescence quenching 
probes. These findings clearly highlight that incorporation of a neutral water-
soluble conjugate oligomer in conjunction with attachment of biorecognition 
elements to both FRET components is effective for highly-selective CPE-
based label-free visual protein sensing. In addition, this molecular pairing 




by choosing corresponding recognition groups as the side chains, such as 
biotin for streptavidin.  
Finally, to extend the application of CPE-based FRET sensors from 
solution to cell, cationic conjugated oligoelectrolyte substituted POSS is 
synthesized for signal amplification in cell via FRET (Chapter 7). This 
molecule can be treated as a unimolecular nanoparticle having shape-
persistent three-dimensionality with a diameter of ~3.6 nm. Due to its small 
diameter, this fluorescent nanoparticle can enter cellular nuclei, which is rarely 
observed for other fluorescent nanomaterials. Moreover, superior to traditional 
CPEs, it has an extremely high PL quantum yield (0.80) in buffer at a high 
ionic strength of 150 nM. Efficient FRET from this nanoparticle to dsDNA-
intercalated EB is observed, leading to the 52-fold amplified fluorescence of 
EB emission in solution. With these desirable features, utilization of the CPE-
based nanoparticle and EB as a bicomponent FRET probe not only allows for 
visual discrimination of dsDNA from ssDNA, but also enables to clearly 
image the cell with weakly emissive dyes.  
 
Scheme 8.1. Schematic illustration of CPE-based FRET probes: single-
component systems (A in Chapter 3 and B in Chapter 4) and bicomponent 




In summary, the CPE-based visual biosensors demonstrated in this thesis 
have advantages such as operating simplicity and detecting generality over 
traditional sensors. They also circumvent the expensive and time-consuming 
biomolecular labeling processes without compromising sensory selectivity and 
sensitivity, providing fast and economically effective manners for real-time in-
situ visual detection of biological substances. On the other hand, efficient 
FRET of CPE-based systems in cell achieved by the design of three-
dimensional nanoparticle architecture illuminates their potential in-vivo 
sensing.  
From the materials viewpoint, two kinds of FRET probes including CPE-
based single-component and bicomponent systems have been developed 
(Scheme 8.1), which possess high fluorescent brightness and effective sensing 
capability in both solution and cell. Comparison of the results in Chapters 3 
and 4 with those in Chapters 5-7 highlights that CPE-based bicomponent 
FRET systems are more flexible and attractive than single-component FRET 
systems for visual sensing. The reasons include: (i) the chemical modification 
of donor and acceptor can be conducted separately and differently, and (ii) the 
color of fluorescent signals can be simply adjusted by varying the blending 
component ratio without synthesizing the new materials for CPE-based 
bicomponent FRET systems.  
Moreover, two effective molecular engineering strategies are presented to 
improve the detection selectivity of CPE-based FRET probes: (i) one is 
utilization of fluorescent dyes with biorecognition capability as the energy 
donor, and (ii) the other is attachment of recognition groups to the side chains 




based probes with visual sensing feature, but also provides new opportunities 
and fundamental guidelines for further advances in CPE-based biological 
applications. 
8.2. Recommendations 
The CPE-based FRET probes developed in this thesis can be further 
improved and extended to other applications, which benefits from the facile 
modification of their molecular structures that enables to diversify their optical, 
water-solubility, biorecognition, and supramolecular organization properties. 
As following, the recommendations for improving CPE-based FRET probes 
for heparin, dsDNA and proteins are given, and then the potential utilities of 
unique CPE-based POSS nanomaterials are discussed. At last, the perspective 
directions that can make full use of CPEs in biological applications are 
pictured.  
For the heparin sensing in Chapter 3, attachment of recognition groups 
with high affinity to saccharides (e.g. boronic acid) as the end group of CPE 
side chains should greatly improve their specific binding and selectivity 
toward heparin.89 In addition, as heparin has a helical conformation,78 CPEs 
with helix-mimic backbones should have the advantage of shape adaptation 
with stronger binding to heparin as compared to their linear counterparts. As a 
consequence, development of CPEs simultaneously possessing helical 
backbones and boronic acid substituents should be promising for improved 
selectivity of CPE-based heparin assays, which have the potential to be used 




For visual nucleic acid sensing in Chapter 4, utilization of a green-
emissive CPE backbone (e.g. PFV) as the energy donor instead of the blue-
emissive PF backbone in Chapter 4 to create the FRET probe may facilitate 
the visual detection as human eyes are most sensitive to green color. 
Furthermore, other intercalating dyes can be tethered to a proper CPE structure 
to achieve a signaling emission at different wavelengths. However, the 
optoelectronic properties of the intercalating dye and the CPE should be 
simultaneously optimized in terms of energy-level alignment as described in 
Chapter 2 in order to achieve efficient FRET.  
For visual protein sensing in Chapters 5 and 6, increasing the water-
solubility while decreasing the charge density of CPEs are crucial for reducing 
the nonspecific interactions and in turn improving the specificity. As well 
known, poly(ethylene glycol) (PEG) is one of the most effective hydrophilic 
building blocks that has been widely integrated into biomaterials to suppress 
nonspecific adsorption of biological substances.187 Therefore, attachment of 
PEG to CPEs as the side chain should be one of the effective ways to achieve 
this goal. However, this method requires the precise control and careful 
selection of PEG length, as it has the possibility to compromise the sensing 
sensitivity. In a similar way as shown in Chapter 6, other proteins could also 
be visually detected by attachment of other affinity groups apart from 
mannose (e.g. biotin for streptavidin). 
In Chapter 7, other fluorescent biorecognition elements in addition to 
intercalating dyes can be used as the energy acceptor to form the FRET 
intracellular probe with the POSS molecule. For instance, utilization of 




certain metal ions may lead to multicolor intracellular sensing of metal ions. 
However, good cell-permeability is required for the used chromophores. 
Moreover, from the materials viewpoint, the emission wavelength, charge 
nature and diameter of POSS-based fluorescent nanoparticles can be easily 
adjusted through chemical modification of fluorescent arms so as to fulfill the 
different requirements of specific applications. In view of their aggregation-
inhabited nanostructures and environment-resistant fluorescence, CPE-based 
POSS nanomaterials are also appropriate for signal amplification in various 
solid-state biological assays, such as DNA and protein microarrays. 
In-vitro and in-vivo sensing and imaging applications will become another 
important direction for CPEs-based materials. This is motived by the 
outstanding fluorescent properties of CPEs and their purely organic 
ingredients that make them more biocompatible as compared to other 
inorganic fluorescent nanomaterials (e.g. semiconductor quantum dots).188 
Ease of attaching reactive groups (e.g. -NH2 and -COOH) to CPEs as the side 
chains pre- and post-polymerization is another advantage, which consequently 
allows for bioconjugation with various recognition elements.  
In contrast to the traditional linear CPEs as shown Chapters 2-6, CPEs 
with intrinsic three-dimensional architectures (e.g. hyperbranched and POSS-
based polymers) or self-assembled nanostructures (e.g. amphiphilic rod-coil 
and graft polymers) should be more desired for bioimaging applications, due 
to their more efficient cellular uptake. Covalent or non-covalent binding of 
these specifically-designed CPEs with other biorecognition biomolecules, such 
as antibodies, peptides and aptamers, having high affinity toward certain cells 




addition, development of CPE-based nanoparticles having suitable size and 
high stability in bloodstream could lead to targeted in-vivo fluorescent imaging. 
CPEs are indeed a unique category of optical materials with many utilities 
that cannot be accomplished by their counterpart organosoluble CPs and also 
small-molecular chromophores. The application of CPEs in biological sensing 
and imaging is still its infancy, and there is much work yet to be carried out 
not only to further understand their interaction and organization in 
physiological conditions, but also to fully exploit their potential structural 
diversity that could potentially embody new functions. However, one thing for 
sure is that concomitant with the rapid development of polymer chemistry, 
materials science and biology, CPEs will grow more and more perfectly and 
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